An evaluation of melanopsin function and light exposure in depressive disorders by Ojha, Govinda
AN EVALUATION OF MELANOPSIN FUNCTION AND 
LIGHT EXPOSURE IN DEPRESSIVE DISORDERS 
Govinda Ojha 
B. Optom 
Submitted in fulfilment of the requirements for the degree of 
Masters of Applied Science 
Medical Retina Laboratory 
Institute of Health and Biomedical Innovation 
School of Biomedical Sciences 
Queensland University of Technology (QUT) 
Australia 
2017 
  
 
 
 
 
i 
 
ABSTRACT  
Aberrant light exposure causes depression in animals through a pathway involving the 
recently discovered intrinsically photosensitive Retinal Ganglion Cells (ipRGCs). The 
photopigment melanopsin expressed in ipRGCs encodes irradiance to signal to the non-
image-forming centres of the brain, including the suprachiasmatic nucleus (SCN) for 
circadian photoentrainment and the olivary pretectal nucleus (OPN) to control the pupil light 
reflex. Mouse models have further identified ipRGC projections to the brain nuclei that 
regulate mood and behaviour. In humans, the post-illumination pupil response (PIPR), a 
sustained pupillary constriction after light offset, is used as a direct and non-invasive 
biomarker of ipRGC function.  
The PIPR amplitude is reduced in humans with seasonal affective disorder (SAD) that 
shows a seasonal variation in depressive episodes with a peak manifestation in winter when 
the solar light exposure is low, but a recent study including patients with non-seasonal 
depressive disorder did not detect ipRGC dysfunction. Moreover, neither study measured the 
ambient light exposure levels in patients with depression for comparison to healthy 
individuals without depression. The knowledge of the role of light coding cells (ipRGCs) in 
major depressive disorder (MDD) is incomplete unless the relationship between ambient light 
exposure levels and melanopsin function is evaluated. This study aims to measure the 
environmental light exposure levels and their relationship with melanopsin-mediated PIPR in 
non-seasonal depression. It is hypothesised that the patients with non-seasonal depression are 
exposed to low light levels and this is associated with impaired melanopsin function.  
A sample of 22 adults was recruited, including people with non-seasonal depression (n 
= 8, median age: 35 years) and healthy age-matched controls (n = 14, median age: 29 years). 
The presence of a DSM-IV MDD was assessed using the Mini International Neuropsychiatry 
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Interview (MINI 6). The severity of depression symptoms was assessed with the Beck 
Depression Inventory (BDI-II). Individuals with recurrent MDD assessed with the MINI and 
a positive screen on the Seasonal Pattern Assessment Questionnaire and the Hamilton 
Depression Rating Scale-SAD (HDRS-SAD) were excluded as SAD. Both groups had visual 
acuity ≥ 6/6, normal colour vision and intraocular pressure (IOP) ≤ 21 mmHg, no corneal and 
lenticular opacities and normal retinae and optic discs. The ipRGC-mediated PIPR was 
measured using a short duration (1 s) high irradiance (15.5 log quanta.cm-2.s-1) short 
wavelength (blue appearing) light stimulus with a custom built Maxwellian view 
pupillometer. Light exposure levels, sleep-wake times and sleep efficiency were determined 
over 2 weeks with an ambulatory light sensor device (Geneactive).  
The mean daily light exposure levels were similar between the groups and there were 
no statistically significant differences between the groups for light exposure levels as a 
function of clock hours, nor in the total number of minutes of exposure to light levels that are 
commonly recommended for depression therapy with bright light (e.g., ≥ 10,000 lux, ≥ 5000 
lux and ≥ 2500 lux). There were no statistically significant differences in the mean % 
baseline PIPR amplitude between the patients with depression (mean % baseline ± SD, 60.31 
± 9.2) and healthy control participants (mean % baseline ± SD, 60.25 ± 6.5).  
This study expands previous knowledge in depressive disorder to demonstrate that non-
seasonal depression is independent of an individual’s ambient light exposure level and the 
patients with non-seasonal depression can have normally functioning light coding ipRGCs. 
While depression is a multi-factorial condition, future studies may focus on determining 
whether ipRGC sub-types other than M1 with direct projections to brain mood centres have a 
role in the pathophysiology of non-seasonal depression.  
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CHAPTER 1: INTRODUCTION 
Depressive disorders are common mental health disorders, occurring in 2 to 17% of the 
population, or more than 350 million people worldwide (Choe, Emslie, & Mayes, 2012; 
Ferrari, Somerville, Baxter, Norman, Patten, Vos, & Whiteford, 2013; Luppa, Sikorski, Luck, 
Ehreke, Konnopka, Wiese, Weyerer, König, & Riedel-Heller, 2012; World Health 
Organization, 2008). Depressive disorders are more common in females than in males with 
twice the number of females suffering from depression than males (Girgus & Yang, 2015). 
Differences in biological response to stress, exposure to stressful life events and social equity 
have been thought as few of the several factors leading to the higher proportion of females 
with depression (Girgus et al., 2015). Given the increasing global prevalence of depressive 
disorders, it is imperative to understand the pathophysiology of depression to inform the 
development of new treatments.  
Several studies have linked the role of the recently discovered inner retinal melanopsin- 
expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) to the regulation of 
effect of light on mood and cognitive functions in humans (Laurenzo, Kardon, Ledolter, 
Poolman, Schumacher, Potash, Full, Rice, Ketcham, Starkey, & Fiedorowicz, 2016; 
Roecklein, Wong, Ernecoff, Miller, Donofry, Kamarck, Wood-Vasey, & Franzen, 2013) and 
animals (Legates, Altimus, Wang, Lee, Yang, Zhao, Kirkwood, Weber, & Hattar, 2012). 
Aberrant light exposure can cause depressive behaviour in rodents with intact ipRGCs, but 
not in those lacking ipRGCs, implicating the role of ipRGCs in regulating the effect of light 
on mood  (Legates et al., 2012). The regulation of mood in the animal models is thought to be 
mediated through ipRGC projections to the brain mood centres (Fernandez, Chang, Hattar, & 
Chen, 2016; Gooley, Lu, Fischer, & Saper, 2003; Hattar, Kumar, Park, Tong, Tung, Yau, & 
Berson, 2006). In addition, ipRGCs encode irradiance with major inputs to the non-image-
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forming centres of the brain, including the suprachiasmatic nucleus (SCN) to adjust the 
central circadian clock to the ~ 24 hours light-dark cycle (Berson, Dunn, & Takao, 2002; 
Czeisler, Shanahan, Klerman, Martens, Brotman, Emens, Klein, & Rizzo, 1995a; Fernandez 
et al., 2016; Gooley et al., 2003; Warner, Jethwa, Wyse, I'Anson, Brameld, & Ebling, 2010) 
and to the olivary pretectal nucleus (OPN) to regulate the pupillary light response (PLR) and 
the post-illumination pupil response (PIPR) (Baver, Pickard, Sollars, & Pickard, 2008; Ecker, 
Dumitrescu, Wong, Alam, Chen, LeGates, Renna, Prusky, Berson, & Hattar, 2010; Gamlin, 
McDougal, Pokorny, Smith, Yau, & Dacey, 2007; Gooley et al., 2003; Hattar et al., 2006; 
Hattar, Liao, Takao, Berson, & Yau, 2002; Markwell, Feigl, & Zele, 2010).  
The PLR is the pupil constriction in response to light and is contributed by both inner 
retinal ipRGCs and outer retinal rods and cones (Adhikari, Zele, & Feigl, 2015b; 
Barrionuevo, Nicandro, McAnany, Zele, Gamlin, & Cao, 2014; Joyce, Feigl, Cao, & Zele, 
2015; McDougal & Gamlin, 2010) whereas the PIPR, which is a sustained pupil constriction 
after light offset (Adhikari et al., 2015b; Gamlin et al., 2007; Hansen, Sander, Kessel, 
Broendsted, Kawasaki, Herbst, LundAndersen, Medicinska, & Oftalmiatrik, 2012; Kankipati, 
2009; Kankipati, Girkin, & Gamlin, 2010; Markwell et al., 2010; McDougal et al., 2010; 
Park, Moura, Raza, Rhee, Kardon, & Hood, 2011; Young & Kimura, 2008), is predominantly 
driven by ipRGCs (Adhikari, Feigl, & Zele, 2016a; Gamlin et al., 2007). The measurement of 
the PIPR allows for the direct and in vivo assessment of ipRGC function in humans (Adhikari 
et al., 2015b; Feigl & Zele, 2014; Gamlin et al., 2007; Kankipati et al., 2010; Markwell et al., 
2010; McDougal et al., 2010; Young et al., 2008). Collectively, the PIPR has been assessed 
as a direct and non-invasive biomarker of ipRGC function in human eyes with and without 
retinal disease (Adhikari, Zele, Thomas, & Feigl, 2016b; Feigl, Mattes, Thomas, & Zele, 
2011; Feigl et al., 2014; Feigl, Zele, Fader, Howes, Hughes, Jones, & Jones, 2012; Kankipati 
et al., 2010; Kankipati, Girkin, & Gamlin, 2011; Kelbsch, Maeda, Strasser, Blumenstock, 
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Wilhelm, Wilhelm, & Peters, 2016; Markwell et al., 2010; Maynard, Zele, & Feigl, 2015) and 
therefore can also be used to measure the input of ipRGC projections to the brain mood 
centres to evaluate the melanopsin function in depressive disorders (Laurenzo et al., 2016; 
Roecklein et al., 2013).  
IpRGCs have highest sensitivity to short wavelength (bluish) light (max = 482 nm) 
(Adhikari et al., 2015b; Feigl et al., 2011; Feigl et al., 2014; Gamlin et al., 2007; Markwell et 
al., 2010; McDougal et al., 2010; Young et al., 2008), and blue light with high melanopsin 
excitation has been shown to have an antidepressant effect in humans with major depressive 
disorders (MDD), including seasonal affective disorder (SAD) (Glickman, Byrne, Pineda, 
Hauck, & Brainard, 2006; Meesters, Dekker, Schlangen, Bos, & Ruiter, 2011) and non-
seasonal depression (Lieverse, Van Someren, Nielen, Uitdehaag, Smit, & Hoogendijk, 2011; 
Royer, Ballentine, Eslinger, Houser, Mistrick, Behr, & Rakos, 2012). SAD is a type of 
depression that shows a peak manifestation of depressive symptoms in winter when the solar 
light exposure is low (Eastwood & Peter, 1988). The prevalance of SAD ranges from 0% to 
9.7% worldwide depending on the latitude (Magnusson, 2000). Non-seasonal depression does 
not show seasonal variation of depressive symptoms and the worldwide prevalence of non-
seasonal depression is higher than SAD (7-17%) (Luppa et al., 2012). The mechanism by 
which ocular light exposure alleviates the depressive symptoms in patients with MDD is not 
understood unless the relationship between environmental light exposure and ocular 
photoreception function of the main light coding cells is known. While the  patients with 
SAD are exposed to a similar ambient light exposure level as healthy individuals, irrespective 
of the season (Graw, Recker, Sand, Kräuchi, & Wirz-Justice, 1999; Guillemette, Hébert, 
Paquet, & Dumont, 1998; Oren, Moul, Schwartz, Brown, Yamada, & Rosenthal, 1994), 
studies have linked the role of retinal photoreception by rods and cones to justify the positive 
effect of light in SAD (Lavoie, Lam, Bouchard, Sasseville, Charron, Gagné, Tremblay, 
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Filteau, & Hébert, 2009; Ozaki, Rosenthal, Moul, Schwartz, & Oren, 1993; Szabó, Antal, 
Tokaji, Kálmán, Kéri, Benedek, & Janka, 2004). The cone-pathway mediated visual contrast 
sensitivity is reported to be similar or higher in SAD patients than in healthy individuals 
(Szabó et al., 2004; Wesner & Tan, 2006) whereas studies on contrast sensitivity in non-
seasonal depression are inconsistent showing an increased (Wesner et al., 2006) or decreased 
(Bubl, Tebartz Van Elst, Gondan, Ebert, & Greenlee, 2009; Fam, Rush, Haaland, Barbier, & 
Luu, 2013) sensitivity among the patients with depression. Nevertheless, electrophysiology 
studies consistently demonstrate a reduction in neuroretinal function in both SAD (Hébert, 
Beattie, Tam, Yatham, & Lam, 2004; Hébert, Dumont, & Lachapelle, 2002; Lam, Beattie, 
Buchanan, & Mador, 1992; Lavoie et al., 2009) and non-seasonal depression (Bubl, Kern, 
Ebert, Bach, & van Elst, 2010; Bubl, Kern, Ebert, Riedel, van Elst, & Bach, 2015) indicating 
that there are changes in retinal function involving the outer retinal rod and/or cone pathways.  
Interestingly, the inner retinal ipRGC mediated PIPR amplitude is reduced in SAD in winter 
when depressive episodes of the patients are at peak (Roecklein et al., 2013). A recent study, 
however, observed no difference in the PIPR in patients with MDD including SAD  
compared to healthy individuals (Laurenzo et al., 2016). The discrepancy in the PIPR results 
among the patients with depression between the two studies may have occurred due to the 
PIPR measurements in the (Laurenzo et al., 2016) study being conducted during both the 
winter and summer months when depression and remission occur respectively, possibly 
altering the melanopsin function with season (Münch, Kourti, Brouzas, & Kawasaki, 2016). 
In particular, Laurenzo et al. (2016) demonstrated that the PLR to low intensity short and 
long wavelength light stimuli, which preferentially reflects the outer retinal photoreception 
when measured using the transient pupil response (Adhikari et al., 2015b; Feigl et al., 2012; 
Kardon, Anderson, Damarjian, Grace, Stone, & Kawasaki, 2009), is reduced in patients with 
MDD. Although, the PIPR and transient PLR in response to a high-intensity and short 
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wavelength light stimulus have a significant positive relationship with light exposure in MDD 
(Laurenzo et al., 2016), no study has compared the ambient light exposure through 24 hours 
in a day  in individuals with and without non-seasonal MDD. Treatment of depression with 
ocular light exposure is commonly provided through light levels ranging from 2500 to 10,000 
lux (Even, Schröder, Friedman, & Rouillon, 2008; Gallin, Terman, Reme, Rafferty, Terman, 
& Burde, 1995; Glickman et al., 2006; Haffmans, Schouten, & den Hoed, 2008; Kräuchi, 
Wirz-Justice, & Graw, 1990; Meesters et al., 2011; Naus, Burger, Malkoc, Molendijk, & 
Haffmans, 2013; Szabó et al., 2004; Winkler, Pjrek, Praschak-Rieder, Willeit, Pezawas, 
Konstantinidis, Stastny, & Kasper, 2005; Wirz-Justice, Graw, Roosli, Glauser, & 
Fleischhauer, 1999), but no study has evaluated the habitual exposure durations to these 
ranges of illuminance of ambient light in patients with non seasonal depressive disorders. 
Hence, the relationship between light exposure and retinal photoreception that mediates light 
therapy in non-seasonal depression is not known.   
This study aims to evaluate the environmental light exposure levels and their 
relationship to the inner and outer retinal photoreceptor function using the pupil light 
response and contrast sensitivity in individuals with and without non-seasonal depression. 
Using a Maxwellian view pupillometer and optimised stimulus paradigms that are robust in 
detecting subtle melanopsin defects (Adhikari et al., 2015b; Adhikari et al., 2016b), the 
present study tests the hypothesis that individuals with non-seasonal depression have reduced 
PIPR and PLR amplitudes that are associated with  lower daily ambient light exposure levels 
compared to the healthy individuals. The study further examines the hypothesis that patients 
with non-seasonal depression have reduced visual contrast sensitivity than  healthy people. 
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CHAPTER 2:  LITERATURE REVIEW 
This chapter includes review of the current literature on melanopsin-expressing 
intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) and their role in mediating the 
pupil light reflex and mood through their projections to different brain areas. With ipRGCs, 
rods and cones being the main “light sensors” of the visual system, the role of light exposure 
in the etiology of depressive disorders and their relationship with rod, cone and ipRGC 
function are reviewed. The review leads to the experimental aims and hypothesis of the 
thesis. 
2.1 MELANOPSIN-EXPRESSING INTRINSICALLY 
PHOTOSENSITIVE RETINAL GANGLION CELLS: MORPHOLOGY 
AND RETINAL DISTRIBUTION  
Light-sensitive melanopsin was first discovered in the skin of the frog (Xenopus laevis) 
(Provencio, Jiang, De Grip, Hayes, & Rollag, 1998; Rollag, 1996; Seldenrijk, Hup, de Graan, 
& van de Veerdonk, 1979).  However, the photic entrainment in mammalian vertebrates is 
not extraocular (Nelson & Zucker, 1981) suggesting ocular photopigments being involved in 
non-image-forming functions in mammals. Only four distinct photopigments were thought to 
exist in the mammalian retina; one rod and three cone opsins, although there was an early 
evidence of the existence of another photoreceptor class that regulated iris movement in blind 
mice (Keeler, 1927). In addition, a reduction in the release of melatonin in response to light 
in blind patients with rod and cone degeneration further suggested the presence of an 
unknown photopigment (Czeisler et al., 1995a; Lockley, Skene, Arendt, Tabandeh, Bird, & 
Defrance, 1997). A fifth class of photopigment, melanopsin, expressed in the ganglion cells 
in the mammalian retina, was subsequently discovered and described using  nocturnal mouse 
models (Berson et al., 2002; Hattar et al., 2002; Provencio, Rollag, & Castrucci, 2002). 
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Melanopsin-expressing retinal ganglion cells were subsequently identified in non-human 
primates and in human’s retinae (Dacey, Liao, Peterson, Robinson, Smith, Pokorny, Yau, & 
Gamlin, 2005) and these cells constitute 0.2% (~3,000) in the primates  and 0.4% (~4,400) 
human retinae (Liao, Ren, Peterson, Marshak, Yau, Gamlin, & Dacey, 2016). 
IpRGCs are defined as a group of cells constituting uniform morphology and 
physiology (Berson et al., 2002; Hattar et al., 2002). They can be histologically differentiated 
in the retina from the midget and parasol ganglion cells of the parvocellular and 
magnocellular pathway, based on their large cell bodies (diameter 19±3 µm to 23±3 µm in 
human) and dendritic trees (diameter 646±151 µm to 690±148 um in human) which arborise 
in the inner plexiform layer (Dacey et al., 2005; Liao et al., 2016). The dendritic field 
diameter in both human and macaque retinae increases from the fovea to the periphery with 
the dendritic field diameter in both human and macaque retina increasing from ~250 µm at 
the fovea to ~1200 µm at ~16 mm of retinal eccentricity with dendrites at the fovea forming a 
plexus surrounding the foveal pit (Dacey et al., 2005; Jusuf, Lee, Hannibal, & Grünert, 2007; 
Liao et al., 2016). The peak ipRGC density decreases from the fovea (30-35 cells/mm2) to the 
peripheral retina (8-10 cells/mm2) through ~16 mm of retinal eccentricity in the human retina 
(Liao et al., 2016). However, in the mouse retina, the highest ipRGC density was seen in the 
superior temporal quadrant (Galindo-Romero, Jiménez-López, Garcia-Ayuso, Salinas-
Navarro, Nadal-Nicolás, Agudo-Barriuso, Villegas-Pérez, Avilés-Trigueros, & Vidal-Sanz, 
2013; Hattar et al., 2002). 
Figure 1 shows the different ipRGC sub-types and their dendritic stratification within 
the inner plexiform layer. Together with the two types of ipRGCs, the outer stratifying (M1) 
and inner stratifying (M2) that were originally discovered, a third bistratified ipRGC (M3) 
was identified in the mouse retina (Schmidt & Kofuji, 2011b; Schmidt, Taniguchi, & Kofuji, 
2008; Viney, Balint, Hillier, Siegert, Boldogkoi, Enquist, Meister, Cepko, & Roska, 2007). In 
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humans and macaques, two sub-types of ipRGCs (M1 and M2) have been identified (Liao et 
al., 2016). The M1 cells are the most prominent ipRGCs in number and have the largest 
dendritic branches, but with the smallest soma size (Berson, Castrucci, & Provencio, 2010; 
Provencio et al., 2002). The dendrites of outer stratifying M1 ipRGCs extend to the OFF sub-
laminae of the inner plexiform layer (Berson et al., 2002; Hattar et al., 2006; Hattar et al., 
2002; Liao et al., 2016) and receive OFF input when the signals from amacrine cells have 
been blocked (Wong, Dunn, Graham, & Berson, 2007).  
The outer stratifying M1 melanopsin cells receive synaptic contact from dopaminergic 
axons of the amacrine cells, whereas the inner stratifying M2 melanopsin cells are contacted 
by DB6 bipolar cells (Liao et al., 2016; Viney et al., 2007). A small number of M1 ipRGCs 
(~ 10%) have been identified in the mouse retina that have axonal collaterals projecting back 
to the inner plexiform layer where they provide synaptic input to dopaminergic amacrine 
cells that are thought to be involved in the modulation of cone-driven light adaptation (Joo, 
Peterson, Dacey, Hattar, & Chen, 2013; Prigge, Yeh, Liou, Lee, You, Liu, McNeill, Chew, 
Hattar, Chen, & Zhang, 2016; Viney et al., 2007). The wild-type mice showed an increase in 
the b-wave of the light-adapted ERG amplitude while no change in the b-wave amplitude 
under similar condition was seen in the mice lacking M1 ipRGCs. The ERG response was 
restored by the injection of dopamine receptor agonist (Prigge et al., 2016) indicating a 
possible role of M1 ipRGCs in image forming visual functions as retrograde light signaling 
from melanopsin to dopaminergic amacrine cells triggers the release of dopamine (Dkhissi-
Benyahya, Coutanson, Knoblauch, Lahouaoui, Leviel, Rey, Bennis, & Cooper, 2013), a 
neurotransmitter that has role in the light-adapted visual function (Jackson, Ruan, Aseem, 
Abey, Gamble, Stanwood, Palmiter, Iuvone, & McMahon, 2012).  
M1 ipRGCs have been further classified into 2 distinct sub-types in mice based on the 
expression of Brn3b transcription factor (Chen, Badea, & Hattar, 2011). Brn3b-negative M1 
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ipRGCs project the SCN for circadian photoentrainment and Brn3b-positive ipRGCs project 
other brain targets, including the OPN for regulating the pupil light reflex (Chen et al., 2011). 
Other ipRGC sub-types arborising in the ON sub-laminae of the inner plexiform layer also 
show a Brn3b expression (Chen et al., 2011). Projection to the mood centres by outer 
stratifying (M1) ipRGCs, that share similar expression to Brn3b as inner stratifying (M2, M4 
and M5) ipRGCs, have not been confirmed in mice and humans.  Yet, it is confirmed in mice 
that pupillary light response and circadian photoentrainment are brought about by different 
M1 ipRGC sub-types indicating the two processes being independent (Chen et al., 2011). 
Similar Brn3b based differentiation of ipRGCs and projections of M1 ipRGCs in humans is 
not known. 
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Figure 1: The schematic of retinal layers in a mouse model showing ipRGC sub-types. 
The outer retina comprises a photoreceptor layer that contains rods and cones that synapse 
with bipolar cells in the outer plexiform layer. The inner nuclear layer contains the cell bodies 
of bipolar cells that synapse with the dendrites of ipRGCs in the inner plexiform layer.  The 
ganglion cell layer contains the ipRGCs. 5 sub-types of ipRGCs (M1, M2, M3, M4 and M5) 
with their dendritic stratification to the inner plexiform layer are shown (see text for detail).  
The expression of melanopsin in M1 ipRGCs is higher than that in other ipRGC sub-
types (Baver et al., 2008; Hattar et al., 2006). M2 cells have larger soma, dendritic length, 
dendritic field and more complex dendritic arbors than M1 cells (Liao et al., 2016; Schmidt & 
Kofuji, 2009). M2 ipRGCs are 10 times less sensitive to 480 nm light than M1 cells (Schmidt 
et al., 2009). M2 cells are extended into the ON sub-laminae of the inner plexiform layer 
(Dacey et al., 2005; Liao et al., 2016; Schmidt et al., 2008). M3 ipRGCs have bi-stratified 
dendritic arbors encroaching both ON and OFF sub-laminae of the inner plexiform layer 
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(Provencio et al., 2002; Schmidt et al., 2011b; Warren, Allen, Brown, & Robinson, 2003). 
M3 ipRGCs are identical to M2 with respect to the size of their soma and dendritic branching 
(Schmidt et al., 2011b). An additional two types of ipRGCs named M4 and M5 were 
identified in the mouse retina (Ecker et al., 2010), which Berson et al. (2010) described as 
large alpha-like retinal ganglion cells (RGCs). M4 and M5 ipRGCs express weak melanopsin 
and are less intrinsically photosensitive than M1, M2 and M3 (Ecker et al., 2010; Estevez, 
Fogerson, Ilardi, Borghuis, Chan, Weng, Auferkorte, Demb, & Berson, 2012). The dendrites 
of M4 and M5 ipRGCs stratify into the ON sub-laminae of the inner plexiform layer (Ecker 
et al., 2010; Estevez et al., 2012).  M4 ipRGCs have the largest somas, thickest dendrites and 
a more radiating dendritic trees and these cells possess larger ON-centre and OFF-surround 
receptive fields than other ipRGC sub-types (Ecker et al., 2010; Estevez et al., 2012). These 
cells resemble ON alpha-like conventional retinal ganglion cells in mice and exhibit a 
sustained and robust response like M2 cells (Estevez et al., 2012) with a higher intrinsic 
response threshold (Berson et al., 2010; Estevez et al., 2012). M5 ipRGCs are small with 
dense and bushy dendritic processes innervating the inner (ON) sub-laminae of the inner 
plexiform layer (Ecker et al., 2010). M4 and M5 ipRGCs are believed to project to the dorsal 
lateral geniculate nucleus (LGNd) and superior colliculus (SC) and are thought to contribute 
to image forming visual functions (Ecker et al., 2010; Estevez et al., 2012). Recent evidence 
suggests that there are more than 5 sub-types of ipRGCs (personal communication with Prof 
D Berson, Friedenwald lecture, Annual Meeting of the Association of research in Vision and 
Ophthalmology, 2015).  
In conclusion, there are at least five ipRGCs sub-types in rodents and as yet, only two 
ipRGC sub-types have been identified in humans and non-human primates, the outer 
stratifying M1 and inner stratifying M2 ipRGCs. The axonal projection of ipRGCs through 
the optic nerve to the brain areas regulating the pupil light reflex (Baver et al., 2008; Ecker et 
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al., 2010; Gooley et al., 2003; Hattar et al., 2006; Hattar et al., 2002), circadian rhythm 
(Baver et al., 2008; Berson et al., 2002; Gooley, Lu, Chou, Scammell, & Saper, 2001; Gooley 
et al., 2003; Hannibal, Hindersson, Østergaard, Georg, Heegaard, Larsen, & Fahrenkrug, 
2004; Hattar et al., 2002) and mood (Davis & Whalen, 2001; Hattar et al., 2006; Hattar et al., 
2002; Matsumoto & Hikosaka, 2007; Schmidt, Chen, & Hattar, 2011a), have been 
demonstrated in rodents,  and these will be reviewed in the following sections. 
2. 2 INTRINSICALLY PHOTOSENSITIVE RETINAL GANGLION 
CELL CONTRIBUTIONS TO THE PUPIL LIGHT REFLEX  
The Olivary Pretectal Nucleus (OPN) is the brain centre for regulation of the pupil light 
response in mammals (Gamlin, Zhang, & Clarke, 1995). The OPN receives 45% of its 
innervation from M1 and 55% from M2 ipRGCs (Baver et al., 2008) in mice. M1 ipRGCs 
project to the shell of the OPN that controls the pupil light response and M2 ipRGCs 
innervate the OPN core, but its function is unknown (Baver et al., 2008; Ecker et al., 2010; 
Gooley et al., 2003; Hattar et al., 2006; Hattar et al., 2002). Although the photopigment 
density of ipRGCs (~ 3 um-2) is lower than that of rods and cones (~ 25,000 um-2) (Liebman, 
Parker, & Dratz, 1987), ipRGCs exhibit a larger single photon intrinsic response (Do, Kang, 
Xue, Zhong, Liao, Bergles, & Yau, 2009). IpRGCs also receive extrinsic synaptic impulses 
from rods and cones to serve non-image-forming functions (Belenky, Smeraski, Provencio, 
Sollars, & Pickard, 2003; Dacey et al., 2005; Jusuf et al., 2007; Schmidt & Kofuji, 2010; 
Wong et al., 2007). However, the extrinsic response has a higher temporal resolution 
(Barrionuevo et al., 2014; Joyce et al., 2015) than the intrinsic response which is slower and 
more sustained (Barrionuevo et al., 2014; Gamlin et al., 2007; Joyce et al., 2015; Kardon et 
al., 2009; Markwell et al., 2010). The peak spectral sensitivity of the melanopsin 
photopigment (max = 482 nm) lies between those of S-cones (max = 440 nm) and rods 
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(max = 507 nm) (Gamlin et al., 2007; Markwell et al., 2010; McDougal et al., 2010). Figure 
2 shows the spectral sensitivities of ipRGCs, rods and L, M, S-cones.  
 
Figure 2: The spectral sensitivity curves of human photoreceptors.  
The peak spectral sensitivities of the S-cone (max = 440 nm), ipRGC (max = 482 nm), rod 
(max = 507 nm), M-cone (max = 543 nm) and L-cone (max = 566 nm) are shown (from 
Feigl & Zele, 2014).  
Figure 3 shows a schematic of the pupillary pathway that modulates the pupillary light 
reflex in primates. The autonomic pupil response is regulated by the autonomic innervations 
to iris muscles, the sphincter and the dilator pupillae (for review, see McDougal & Gamlin, 
2015). The sphincter pupillae consist of annular bands of muscle fibres that receive 
cholinergic (parasympathetic) innervation to induce pupillary constriction in response to a 
light stimulus, whereas the dilator pupillae are radial muscle fibres that receive adrenergic 
(sympathetic) innervations at light offset to cause pupillary dilation (McDougal & Gamlin, 
2015). The optic nerve serves as an afferent pathway projecting to the OPN which relays to 
the Edinger-Westphal nuclei (Gamlin et al., 1995). The preganglionic fibres of the 
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parasympathetic pathway that originate from the Edinger-Westphal nuclei travel along the 
oculomotor nerve to synapse with the postganglionic neurons in the ciliary ganglion. The 
sympathetic pathway that originates at the ciliospinal centre located at C8-T2 in the spinal 
cord travels up to the superior cervical ganglion in the neck where the neurons synapse with 
the postganglionic neurons. The postganglionic neurons ascend up the neck through the 
ciliary ganglion and enter into the eye via the short or long ciliary nerves or through the optic 
canal to innervate the dilator muscle of the iris causing pupillary dilation (McDougal et al., 
2015). The parasympathetic and sympathetic innervations contribute to the steady state 
(baseline) pupil diameter, which is influenced by several factors, including the retinal 
illuminance, accommodation, emotional state (e.g., fear, stress, depression) and cognitive 
functions (Bradley, Miccoli, Escrig, & Lang, 2008; Guinjoan, Bernabó, & Cardinali, 1995; 
Steinhauer, Siegle, Condray, & Pless, 2004). Cholinergic agonists like pilocarpine constrict 
the pupil while cholinergic antagonists (e.g., atropine, tropicamide) and adrenergic agonists 
(e.g., Phenylephrine) cause pupillary dilation (McDougal et al., 2015).  
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Figure 3: The pupillary light reflex pathway in primates.  
The optic nerve relays the light signal to the Olivary Pretectal Nucleus to regulate the pupil 
light reflex. The Edinger-Westphal nuclei mediate the consensual pupil light reflex as each of 
them project nerve fibres to both ipsilateral and contralateral pupils. The oculomotor nerve 
serves as an efferent pathway for initiating pupillary constriction in response to a light 
stimulus. The parasympathetic nerve fibres (red dashed line) and the sympathetic nerve fibres 
(blue dashed line) are shown (see text for detail).   
The pupil light reflex (PLR) is the pupillary constriction during light stimulus and both 
outer (rods and cones) and inner (ipRGCs) retinal photoreceptors contribute to the PLR 
(Adhikari et al., 2015b; Gamlin et al., 2007; Kardon et al., 2009; McDougal et al., 2010; Park 
et al., 2011). Figure 4 shows the pupillary light reflex in response to a 1 s short wavelength, 
bluish (464nm) pulsed stimulus during light stimulus (PLR) and after light offset (PIPR) with 
different metrics that can be derived from the PLR and PIPR.  
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Figure 4: The pupil light response plot of a healthy 29-year-old female with normal 
ocular health.  
The plot of the pupil light response over time to a 1 s short wavelength, bluish (464 nm) light 
stimulus (black rectangle) is shown. The gray line shows the exponential model fitted over 
the PIPR trace (blue) in response to a 1 s short wavelength light stimulus. The 6 s PIPR 
metric represents the pupillary constriction at 6 s after the light offset (gray vertical line). The 
plateau metric is the plateau of the exponential model. The PLR is described by the PLR 
latency, transient PLR and peak pupil constriction. The peak constriction amplitude is the 
maximum pupil constriction during the light onset. The PLR latency is the time to 1% 
constriction during light onset and the transient PLR is the peak change in pupil diameter 
between 180 to 500 ms of light onset (see Adhikari et al, (2015b) for an overview of the PLR 
and PIPR metrics).  
The transient PLR is the initial pupil constriction (peak constriction between 180 to 500 
ms) and it measures the outer retinal rod and cone contribution to the PLR (Adhikari et al., 
2016b; Feigl et al., 2012; Kardon et al., 2009; Laurenzo et al., 2016). The longer time to peak 
constriction amplitude (1.4 - 1.9 s) in response to a short wavelength light stimulus of 
irradiance > 11 log quanta.cm-2sec-1 is indicative of a slower response from the melanopsin 
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(Adhikari et al., 2015b; Joyce et al., 2015). The PLR to a short duration pulsed stimulus (< 10 
s) is dominated by rods with a minimal contribution by cones (McDougal et al., 2010). The 
PLR to longer duration stimuli (> 10 s) and at low irradiance (< 7 log quantacm-2sec-1) below 
the melanopsin threshold  (Dacey et al., 2005; Wong, 2012) has contributions from rods only 
(Markwell et al., 2010; McDougal et al., 2010). Rod contributions to the PLR at higher 
irradiances (> 11 log quanta.cm-2.sec-1) and long duration (> 10 s) stimuli are minimal and 
PLR is mainly contributed by ipRGCs (McDougal et al., 2010).  
The PLR measured with a sine wave sinusoidal light stimulus evaluates the response of 
both inner and outer retinal photoreceptors (Feigl et al., 2014; Maynard et al., 2015). A phasic 
amplitude percentage metric can be derived that measures the phasic peak-to-trough 
amplitude during the stimulus presentation reflecting the inner and outer retinal interaction 
(Feigl et al., 2014; Maynard et al., 2015). The PLR in response to a sinusoidal light stimulus  
can be derived as a combined vector sum of the inputs from rod, cone and melanopsin 
(Barrionuevo et al., 2014). At low irradiance (< 11.8 log quanta.cm-2.sec-1) the PLR is 
contributed by rod and cone reflecting outer retinal contribution (Barrionuevo et al., 2014). 
At high irradiance (> 11.8 log quanta.cm-2.sec-1), the PLR is contributed by melanopsin and 
cones (Barrionuevo et al., 2014). At an intermediate range of irradiance (11.8 - 12.1 log 
quanta.cm-2.sec-1), the PLR in response to a sinusoidal stimulus is contributed by all three 
photoreceptors reflecting the interaction between the inner and outer retina (Barrionuevo et 
al., 2014).  Joyce et al. (2015) demonstrated that phasic peak-trough pupil amplitude is lower 
and the time to initial constriction is longer under high melanopsin excitation condition 
indicating a typical response derived from the inner retina.  At low melanopsin condition, the 
phasic peak to trough amplitude is higher and the time to initial constriction is shorter 
reflecting outer retinal contribution (Joyce et al., 2015). 
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The PIPR is the sustained pupil constriction after light offset (Figure 4). The  PIPR 
amplitude measured > 1.7 s of the light offset reflects melanopsin functions, whereas the 
early redilation phase of the PIPR < 1.7 s after the light offset has contributions from both, 
melanopsin and rhodopsin (Adhikari et al., 2016a). The PIPR amplitude increases with 
increasing retinal irradiance to attain half maximal pupil constriction (> 1.5 mm) at 13.5 log 
quanta.cm-2.sec-1 and then plateaus to maximum constriction (> 2.9 mm) at a corneal 
irradiance of ~ 15 log quanta.cm-2.sec-1 (Adhikari et al., 2015b; Gamlin et al., 2007; Joyce, 
Feigl, & Zele, 2012).  
Several studies have evaluated the PIPR with a range of stimulus paradigms in healthy 
and diseased eyes using different metrics (for review, see Feigl & Zele, 2014). The PIPR has 
been measured as percentage plateau amplitude of the baseline pupil diameter (Plateau PIPR) 
(Adhikari et al., 2015b; Feigl et al., 2011; Gamlin et al., 2007; Kankipati et al., 2010; 
Kankipati et al., 2011; Roecklein et al., 2013), at 6 s after light offset (6 s PIPR) (Adhikari et 
al., 2015b; Laurenzo et al., 2016; Maynard et al., 2015; Park et al., 2011) (Figure 4), as the 
net PIPR which is the difference in plateau PIPR in response to long and short wavelength 
light stimuli (Feigl et al., 2012; Kankipati et al., 2010; Roecklein et al., 2013), and as early 
and late area under the curve (early and late AUCs) (Adhikari et al., 2015b; Herbst, Sander, 
Lund-Andersen, Broendsted, Kessel, Hansen, & Kawasaki, 2012). Although, the net PIPR is 
used to control non-specific factors like fatigue in PIPR, the plateau and 6-second PIPR 
metrics have the lowest coefficient of variation and are therefore recommended for clinical 
studies (Adhikari et al., 2015b).  
While stimuli durations of 1 s (Adhikari et al., 2016a; Adhikari et al., 2016b; Joyce, 
Feigl, & Zele, 2016b; Laurenzo et al., 2016; Park & McAnany, 2015; Park et al., 2011), 10 s 
(Feigl et al., 2011; Feigl et al., 2012; Kankipati et al., 2010; Kankipati et al., 2011) and 30 s 
(Roecklein et al., 2013) are routinely used, the 1 s short duration stimulus is shown to 
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generate a larger PIPR than a long duration 10 s or 30 s pulse possibly because ipRGCs adapt 
to a continuous light pulse (Adhikari et al., 2015b; Joyce, Feigl, & Zele, 2016a; Park et al., 
2011; Wong, Dunn, & Berson, 2005). Importantly, the PLR and PIPR amplitudes vary with 
stimulus field size exhibiting higher constriction and PIPR amplitudes with a larger field size 
(Joyce et al., 2016b; Park et al., 2015) and in the central retina compared to the peripheral 
retina (Joyce et al., 2016b). Based on the previous works (Adhikari et al., 2015b; Joyce et al., 
2016b; Park et al., 2011), a short duration (1 s) short wavelength (465 nm) pulsed stimulus 
with a high corneal irradiance (15.5 log quanta.cm-2.sec-1) and a large field size (field 
diameter 40°) stimulus will be used for determining the melanopsin function in patients with 
non-seasonal depressive disorders in this study. 
The pupil light response in human is measured with a pupillometer to control the light 
input and record the change in pupil diameter, typically under an infra-red illumination 
(Loewenfeld & Lowenstein, 1993). A pupil is a mobile aperture that influences the amount of 
light irradiance reaching the retina.  With a closed-loop condition, the retinal irradiance is 
reduced due to shading by the iris and this decreases the pupil constriction amplitude in 
response to short (1 s) or long (30 s) duration light stimuli. Iris shading is expected with a 
short duration (1 s) light stimulus because of very short pupil constriction latency (200 – 240 
ms) (Adhikari et al., 2015b; Bergamin & Kardon, 2003), causing iris movement for 
approximately 1/4th -1/5th  a second.  Hence, a constant retinal irradiance cannot be achieved 
under a closed-loop condition without the use of pharmacological pupil dilation (Loewenfeld 
et al., 1993). Since, a Newtonian view pupillometer projects a divergent beam under a closed-
loop condition, preclinical changes in the pupil responses may be harder to detect given the 
controlled retinal illumination can only be achieved with a pharmacological dilated pupil that 
allows for the measurement of the largest consensual pupillary response (Adhikari, Pearson, 
Anderson, Zele, & Feigl, 2015a). An open-loop condition allows a complete entry of the light 
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into the eye without iris shading (Loewenfeld et al., 1993) and can be achieved by using a 
Maxwellian view system (Loewenfeld et al., 1993) that focuses the light beam on a small 
area of the pupil to ensure the complete entry of the light irrespective of the pupil size 
(Westheimer, 1966). With a Maxwellian view system, the pupil diameter of the stimulated or 
contralateral eye can be recorded without pupil dilation (Adhikari et al., 2015a).  
Previous studies in major depressive disorder (MDD) and seasonal affective disorder 
(SAD) used Newtonian view pupillometer without pharmacological pupillary dilation 
(Laurenzo et al., 2016; Roecklein et al., 2013) and showed discordant results. The initial 
study of patients with SAD by Roecklein et al. (2013) measured the PIPR amplitude in 
response to a long duration (30 s) short wavelength light stimuli (12.3 log quanta.cm-2.s-1) 
and observed a significant reduction in the PIPR amplitude compared to the healthy controls 
(Roecklein et al., 2013). In contrast, the second study by Laurenzo et al. (2016) measured the 
PIPR in response to a shorter duration (1 s) and a higher irradiance (~ 14.8 log quanta.cm-2.s-
1) short wavelength light stimulus and did not detect a difference in PIPR amplitude in MDD 
patients including SAD compared to healthy controls (Laurenzo et al., 2016). Although, there 
is no study comparing the sensitivity and specificity between the Maxwellian and Newtonian 
optics pupillometers, Maxwellian optics pupillometers have been used to detect subtle 
melanopsin defects in glaucoma suspects, early glaucoma and early age-related macular 
degeneration (Adhikari et al., 2016b; Maynard et al., 2015). Hence, the differences in PIPR 
between the MDD/SAD and healthy group in the previous studies (Laurenzo et al., 2016; 
Roecklein et al., 2013) is expected to have increased with Maxwellian view pupillometers. 
The difference in the PIPR between the studies may also have occurred due to the seasonal 
variation of the PIPR (Münch et al., 2016) in the recent study (Laurenzo et al., 2016) that was 
conducted in both winter and summer months as opposed to the previous SAD study 
(Roecklein et al., 2013), which was conducted in winter when the depressive episodes of the 
21 
 
patients with SAD were at peak. The Laurenzo et al. (2016) study further quantified the peak 
constriction amplitude and transient PLR in response to low intensity red and blue light 
stimuli (~ 11.9 log quanta.cm-2.s-1) and observed a significant reduction in the peak 
constriction and transient PLR amplitudes in MDD (Laurenzo et al., 2016). In the present 
study, the consensual pupil light reflex will be measured using optimised stimulus conditions 
and applying an open-loop Maxwellian view pupillometer with the pupil receiving the high 
irradiance light stimulus being pharmacologically dilated to ensure a constant retinal 
irradiance and to detect subtle melanopsin defect in non-seasonal depression that was not 
detected by Laurenzo et al. (2016) in a mixed cohort of non-seasonal MDD and SAD.  
2.3 PROJECTION OF ipRGCs TO MOOD CENTRES IN THE BRAIN 
This research focuses on the ipRGC projections to the brain mood centres (Davis et al., 
2001; Hattar et al., 2006; Hattar et al., 2002; Matsumoto et al., 2007; Schmidt et al., 2011a) 
based on the recent evidence in humans (Roecklein et al., 2013) and animal models (Legates 
et al., 2012) that ipRGC function can be influenced in depressive disorders. Regulation of 
mood may occur via direct innervation of ipRGCs to mood-regulating centres of the brain 
(e.g., medial amygdala and lateral habenula) and their indirect projections to the mood 
centres via the suprachiasmatic nucleus (SCN) (Hattar et al., 2006; Hattar et al., 2002; 
Schmidt et al., 2011a).  
Regulation of mood via the direct pathway is believed to take place via direct ipRGC 
projections to the brain mood centres (see Figure 5), including the Medial amygdala (MA), 
the lateral habenula (LHb), the locus coeruleus (LC), the ventral tegmental area (VTA), the 
dorsal raphe nucleus (DRN) and the hippocampus (HC). It is not known which ipRGC sub-
type innervates these brain areas. These areas are known to have roles in the stress stimuli 
response (Sara & Bouret, 2012; Schmidt et al., 2011a), behavioural adaptation and regulation 
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of mood in animals (Bayer & Glimcher, 2005; Matsumoto et al., 2007; Sara et al., 2012; 
Schultz, Dayan, & Montague, 1997) and in humans (Campbell, Marriott, Nahmias, & 
MacQueen, 2004; Russo & Nestler, 2013).  
A recent study in a mouse model shows that depression-like behaviours can be 
modulated through a direct aberrant light pathway to the brain mood centres, independent of 
the circadian system (Legates et al., 2012). Nocturnal mice developed depression symptoms 
after being exposed to 3.5 hrs light-dark ultradian cycles with light pulses during the animal’s 
active phase (night). Depression in mice was not driven through the circadian pathway as 3.5 
hrs light-dark pulses presented aberrantly (light pulse at night), as opposed to normal 12 hrs 
light-dark pulse, did not affect the rhythms of the body temperature, general activity and the 
central (SCN) and peripheral (liver) molecular circadian clocks (Legates et al., 2012). 
Conversely, the ultradian aberrant light cycle did not depress the mice that lacked ipRGCs 
(Legates et al., 2012). These findings are consistent with an earlier animal study in mice that 
proposed that the SCN is not required to drive mood and cognition; surgical removal of 
bilateral SCN in rats did not affect their performance during the swim test as it tests several 
mobility behaviours (e.g., swimming, jumping, diving and head shakes) that distinguish 
normal animal from those with depression (Tataroğlu, Aksoy, Yılmaz, & Canbeyli, 2004). 
Light therapy in non-seasonal depression is thought to be driven via the direct mood 
pathway independent of the circadian rhythm (Yamada, Martin-Iverson, Daimon, Tsujimoto, 
& Takahashi, 1995). Although both morning and evening bright light altered the circadian 
phase significantly in patients with non-seasonal depression, there was no relationship 
between the changes in phase shifts and depression scores (Yamada et al., 1995) suggesting 
that the direct mood pathway might have driven mood improvement with light exposure in 
non-seasonal depression. The relationship among ipRGCs projecting to the brain mood 
centres, environmental light exposure, and non-seasonal depression is yet to be determined.   
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The indirect ipRGC pathway in mood regulation originates from the SCN, which is the 
central circadian clock. The SCN receives projections from M1 ipRGCs via the 
retinohypothalamic tract (RHT) in humans (Hannibal et al., 2004) and mice (Baver et al., 
2008; Berson et al., 2002; Fernandez et al., 2016; Gooley et al., 2001; Gooley et al., 2003; 
Hannibal et al., 2004; Hattar et al., 2002). In mice, the SCN receives 99% of the direct 
innervations from ipRGCs, of which 80% of the projection is contributed by M1 and the 
remaining 20% by M2 cells (Baver et al., 2008). IpRGCs also project to other brain circadian 
centres like the intergeniculate leaflet (IGL), the ventral lateral geniculate nucleus (vLGN), 
the ventrolateral preoptic area (VLPO), the lateral hypothalamus (LH) and the 
subparaventricular zone (SPZ) for the circadian functions (Hattar et al., 2006). Unlike the 
SCN, which is the central circadian clock, the VLPO, the LH and the SPZ are peripheral 
circadian clocks that receive photic information directly from ipRGCs and indirectly via the 
SCN for sleep regulation (Gooley et al., 2003; Hattar et al., 2006; Schmidt et al., 2011a).  The 
SCN also contributes to mood regulation via its projections to the brain mood centres such as 
the VTA, the LHb, the LC and the HC (Figure 5 b).  
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Figure 5: Projections of ipRGCs to the brain centres in a mouse model.  
(a) Projections of ipRGCs to mood centres (Green trace), circadian and sleep centres (Black 
trace e.g., SCN, IGL, VLPO) and the pupillary centre (Blue trace, e.g., OPN). (b) Direct and 
indirect projections of ipRGCs to brain areas that regulate mood and circadian 
photoentrainment [Modified from (LeGates, Fernandez, & Hattar, 2014)]. 
These brain areas receive innervations from the SCN to regulate circadian rhythm 
dependent mood and behaviour (Hattar et al., 2006; LeGates et al., 2014). The LC is the 
principal site of norepinephrine synthesis, a neurotransmitter that has a role in processing the 
responses to panic and stress (Sara et al., 2012). The HC has neuronal and hormonal 
connections with the SCN [see Figure 5 (b)] and it is considered a site for learning and 
memory encoding (Karatsoreos & McEwen, 2011; Russo et al., 2013). Experimental studies 
have observed an impairment of hippocampal learning and memory in animals exposed to 
acute and chronic circadian phase shifting (Craig & McDonald, 2008; Devan, Goad, Petri, 
Antoniadis, Hong, Ko, Leblanc, Lebovic, Lo, & Ralph, 2001; Fekete, Van Ree, Niesink, & de 
Wied, 1985) further suggesting that circadian rhythm disruption indirectly affects mood in 
animals. Circadian rhythm and sleep disorders are common in depressive disorder 
(Argyropoulos & Wilson, 2005; Borbély & Wirz-Justice, 1982; Wirz-Justice, 2006). Greater 
degree of sleep fragmentation has been reported in both bipolar and unipolar depression than 
in healthy individuals (Gillin, 1979). Sleep deprivation has further been shown to alter the 
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depressive state from depression to mania (Linkowski, Mendlewicz, Leclercq, Brasseur, 
Hubain, Golstein, Copinschi, & Cauter, 1985). SAD is accompanied by circadian rhythm 
disorders associated with shorter photoperiod and melatonin phase delay in winter (Lewy, 
Sack, Miller, & Hoban, 1987; Wehr, Duncan, Sher, Aeschbach, Schwartz, Turner, 
Postolache, & Rosenthal, 2001). Overall, mood disorders associated with circadian rhythm 
disruption are believed to be driven by the SCN’s innervation to the brain mood centres. 
The SCN is the pacemaker of the central circadian clock (Figure 6). It is a part of the 
hypothalamic-pituitary-adrenal (HPA) axis that constitutes the body stress system (Chrousos, 
1995, 2009; Karatsoreos et al., 2011; Nader, Chrousos, & Kino, 2010). On activation of the 
HPA axis by stress, the adrenal gland cortex releases glucocorticoids (cortisol in humans and 
corticosterone in rodents) (Bao, Meynen, & Swaab, 2008; Chrousos, 2009). Cortisol 
increases calcium ion uptake at the synapses in order to increase the release of 
neurotransmitters that subsequently decreases the stress (Schmidtke, 2013). Circadian 
disruption slows down the HPA axis, resulting in a non-uniform production of the cortisol 
hormone, leading to a poor response to the external stressors and depression (Chrousos, 1995; 
Karatsoreos et al., 2011; Nader et al., 2010). Increased levels of cortisol releasing hormones 
(CRH) and cortisol hormones are associated with increased signs and symptoms of 
depression (Bao et al., 2008).  
The SCN also acts as the central pacemaker of pineal melatonin production. Melatonin 
secretion is regulated by the multi-synaptic neural pathways from the SCN (Moore, 1996; 
Teclemariam‐Mesbah, Ter Horst, Postema, Wortel, & Buijs, 1999). Melatonin levels increase 
in the evening in both nocturnal and diurnal animals. Exposure to bright light, specifically 
short wavelength high irradiance light (5.58 x 1013 photons.cm-2) suppressing nocturnal 
melatonin secretion (Brainard, Hanifin, Greeson, Byrne, Glickman, Gerner, & Rollag, 2001; 
Thapan, Arendt, & Skene, 2001), indicates the role of ipRGCs in regulating melatonin 
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rhythm. The production and duration of active diurnal and nocturnal melatonin production is 
altered in MDD such as bipolar disorder and SAD (Arendt, 1989; Crasson, Kjiri, Colin, Kjiri, 
L’Hermite-Baleriaux, Ansseau, & Legros, 2004; Srinivasan, Smits, Spence, Lowe, Kayumov, 
Pandi-Perumal, Parry, & Cardinali, 2006; Thompson, Franey, Arendt, & Checkley, 1988; 
Wehr et al., 2001) suggesting that mood is related to the ipRGC and the SCN-driven pineal 
melatonin rhythm in response to light. Therefore, circadian rhythm disruption affects mood 
and cognition via the multiple neuronal and hormonal connections of the SCN to the brain 
mood and circadian centres (see Figure 6). 
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Figure 6: The neuronal and hormonal connections of the SCN.  
The SCN is the Master clock that receives photic input from ipRGCs and sends the neuronal 
information (solid lines) to the peripheral clocks (blue symbols): the paraventricular nucleus 
(PVN) and the thalamic relays. The PVN has neuronal connections with the anterior pituitary 
and spinal cord that send neuronal and hormonal (dashed lines) connections to the peripheral 
clocks (pineal gland, peripheral tissues, adrenal gland, pre-frontal cortex (PFC), HC and 
MA). The PFC, HC and MA also send reciprocal information to the PVN and SCN for 
restoring the homeostasis of the HPA axis (developed based on Karatsoreos & McEwen, 
2011) 
In conclusion, ipRGCs directly and indirectly (through the SCN) innervate brain areas 
regulating light-mediated mood in humans and animals. The projection of M1 ipRGCs to the 
brain mood centers in human is unknown.  M1 ipRGCs project to multiple brain nuclei, 
including few mood centers in rodents (Fernandez et al., 2016). If considered same for the 
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humans, measuring the function of M1 ipRGCs using the pupillometric paradigms, non-
image forming light inputs to the brain mood centers may be indirectly measured.  
Light exposure is an established therapy in SAD (Burgess, Fogg, Young, & Eastman, 
2004; Deppe, 2002; Glickman et al., 2006; Golden, Gaynes, Ekstrom, Hamer, Jacobsen, 
Suppes, Wisner, & Nemeroff, 2005; Kräuchi et al., 1990; Lam, Levitt, Levitan, Enns, 
Morehouse, Michalak, & Tam, 2006; Lewy, Bauer, Cutler, & et al., 1998; Terman & Terman, 
2005; Wirz-Justice, Graw, Kräuchi, Gisin, Jochum, Arendt, Fisch, Buddeberg, & Pöldinger, 
1993) and non-seasonal depression (Deltito, Moline, Pollak, Martin, & Maremmani, 1991; 
Deppe, 2002; Epperson, Terman, Terman, Hanusa, Oren, Peindl, & Wisner, 2004; Even et 
al., 2008; Friedman, Even, Dardennes, & Guelfi, 2004; Goel, Terman, Terman, Macchi, & 
Stewart, 2005; Loving, Kripke, Elliott, Knickerbocker, & Grandner, 2005; Naus et al., 2013; 
Terman et al., 2005; Tuunainen, Kripke, & Endo, 2004; Yamada et al., 1995), suggesting an 
impaired light signaling within the retina or altered ambient external light exposure, or a 
combination of both in MDD. This thesis aims to understand the relationship between ipRGC 
function and environmental light exposure in depressive disorders and hypothesises that 
patients with non-seasonal depressive disorders have impaired sensitivity of ipRGCs to 
external light and/or are exposed to lower ambient light levels. The current literature on the 
effect of ambient light exposure in depressive disorder is reviewed below.  
2. 4 AMBIENT LIGHT AND DEPRESSION  
Exposure to ambient environmental light, whether natural or artificial, is a key determinant of 
human mental and physical well-being (Cao & Barrionuevo, 2015a, 2015b; Czeisler, 
Johnson, Duffy, Brown, Ronda, & Kronauer, 1990; Czeisler, Kronauer, Mooney, Anderson, 
& Allan, 1987; Czeisler & Waterhouse, 1995b; Smolders, De Kort, & Van den Berg, 2013). 
Reduction in daylight exposure with seasonal changes has been associated with a decrease in 
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the production of brain-serotonin and vice versa (Lambert, Reid, Kaye, Jennings, & Esler, 
2002). Although, the response from ipRGC is attenuated with recent light adaptation (Joyce 
et al., 2016a; Wong et al., 2005), the effect of long term exposure to bright light on ipRGC 
function is not known. Munch et al. (2016) showed a significantly greater PIPR and PLR 
responses in summer than in winter suggesting lower pupil response with decreasing light 
levels with season. The mechanism of change in light sensitivity of photoreceptors may be 
modulated by the alteration of monoaminergic activity with season and light exposure 
(Goldman, 2001; Lambert et al., 2002).  
Circadian desynchronization has also been recognized to be associated with SAD; short 
photoperiods during winter triggers winter depression (SAD) in some individuals and this is 
hypothesised to be due to a dysfunctional ipRGCs requiring more light to remain euthymic 
(Roecklein et al., 2013; Wehr et al., 2001). The dysregulation of melatonin and dopamine in 
the retina and central nervous system of SAD patients (Lam & Levitan, 2000) may contribute 
to the reduction in the PIPR that is modulated by melatonin levels (Münch, Léon, Crippa, & 
Kawasaki, 2012; Zele, Feigl, Smith, & Markwell, 2011). Light exposure study in a normal 
adult population in San Diego, California, USA found that individuals scoring higher on 
atypical mood symptoms (like in SAD) spent less time in bright illumination (Espiritu, 
Kripke, Ancoli-Israel, Mowen, Mason, Fell, Klauber, & Kaplan, 1994). This association 
between a deficient natural light and depression in humans has been well established (Gou, 
Lau, & Qian, 2015; Harb, Hidalgo, & Martau, 2015).  Evidence also suggests that animals 
exposed to short photoperiod, aberrant light cycle and night-time light demonstrate 
depression-like symptoms that are reversed with antidepressants (Ashkenazy-Frolinger, 
Kronfeld-Schor, Juetten, & Einat, 2010; Ashkenazy, Einat, & Kronfeld-Schor, 2009; 
Bedrosian, Fonken, Walton, Haim, & Nelson, 2011; Fonken, Finy, Walton, Weil, Workman, 
Ross, & Nelson, 2009; Fonken, Kitsmiller, Smale, & Nelson, 2012; Fujioka, Fujioka, 
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Tsuruta, Izumi, Kasaoka, & Maekawa, 2011; Legates et al., 2012; Workman, Manny, 
Walton, & Nelson, 2011). Patients with SAD exposed to similar total daylight levels as those 
without SAD, irrespective of the seasons (Graw et al., 1999; Guillemette et al., 1998; Oren et 
al., 1994), have reduced melanopsin-mediated PIPR (Roecklein et al., 2013), indicates a 
different ocular photoentrainment in patients with SAD than healthy individuals. In other 
words, when light levels are low in winter, individuals with dysfunctional ipRGCs are 
vulnerable to depression and those with healthy ipRGCs are not.  Patients with severe visual 
impairment involving retinal pathologies affecting ipRGC function such as glaucoma 
(Adhikari et al., 2016b; Agorastos, Skevas, Matthaei, Otte, Klemm, Richard, & Huber, 2013; 
Feigl et al., 2011; Kankipati et al., 2011) and age-related macular degeneration (Casten & 
Rovner, 2008; Maynard et al., 2015) suffer from sleep disorders (e.g., increased or decreased 
sleep duration and poor sleep quality)  (Khurana, Porco, Claman, Boldrey, Palmer, & 
Wieland, 2016; Pérez-Canales, Rico-Sergado, & Pérez-Santonja, 2016) and SAD (Madsen, 
Dam, & Hageman, 2015). The relationship between ipRGC function, light exposure, and 
depression in human is yet to be determined. Figure 7 shows a schematic linking the ipRGC 
function in relation to the light exposure and depressive state based on the findings of human 
and animal studies. 
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Figure 7: The schematic representation of current knowledge and hypothetical 
relationships among ambient light, ipRGC function and depression.  
Animals with normal ipRGCs exposed to short ultradian light cycle show depression-like 
symptoms (left upper red quadrant) whereas those exposed to normal light cycle do not 
(Legates et al., 2012) (left blue lower quadrant). Humans exposed to lower daylight in winter 
and have a reduction in ipRGC function, suffer from winter depression (Roecklein et al., 
2013) (right upper red quadrant). It is hypothesised that abnormal ipRGC function found in 
glaucoma (Feigl et al., 2011; Kankipati et al., 2011) and in age-related macular degeneration 
(AMD) (Feigl et al., 2014; Maynard et al., 2015) may lead to depression as can be frequently 
found in these common eye diseases (Agorastos et al., 2013; Casten et al., 2008)  (right red 
lower quadrant). In particular, depression and SAD have been associated with severe visual 
impairment from retinal disorders (Madsen et al., 2015).  
 
To determine the effect of ambient light exposure on patients with depression, light 
exposure needs to be measured. To do this, an Actigraphy device (Actiwatch) can be used. 
An Actigraphy device is an accelerometer-based watch-like device that monitors activity and 
light exposure. Actigraphy is widely used to monitor sleep/wake cycle, circadian rhythm and 
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diagnose sleep disorder (Ancoli-Israel, Cole, Alessi, Chambers, Moorcroft, & Pollak, 2003; 
Sadeh & Acebo, 2002). Geneactive (Activinsights, Kimbolton, Cambridgeshire, UK) and 
Actiwatch 2 (Philips, USA) are the examples of ambulatory devices that are worn around the 
wrist to measure light exposure at the wrist level.  
Light exposure levels that are used to treat depression are duration dependent (Even et al., 
2008; Shirani & St Louis, 2009). Typically, light levels ≥ 2500 lux are used and duration of a 
treatment session commonly decreases with an increase in illumination level (Even et al., 
2008). Most studies showing comparable treatment as psychopharmacotherapy in SAD 
patients used illumination 2500 lux, 5000 lux and 10,000 lux for 2 hrs, 1 hr and ½ hr  
respectively (Even et al., 2008; Gallin et al., 1995; Glickman et al., 2006; Haffmans et al., 
2008; Kräuchi et al., 1990; Meesters et al., 2011; Naus et al., 2013; Szabó et al., 2004; 
Winkler et al., 2005; Wirz-Justice et al., 1999). The outcome of light treatment in comparison 
to the conventional antidepressants in non-seasonal depression also showed similar trend 
when treatment was done with light levels ranging from 2500 lux-10,000 lux (Beauchemin & 
Hays, 1997; Corral, Wardrop, Zhang, Grewal, & Patton, 2007; Kripke, Mullaney, Klauber, 
Craig Risch, & Christian Gillin, 1992; Lieverse et al., 2011; Martiny, Lunde, Unden, Dam, & 
Bech, 2005; Naus et al., 2013; Wirz-Justice et al., 1999; Yamada et al., 1995). Successful 
treatment outcome with these light levels may indicate that patients with depression may not 
spend sufficient time in these light levels and/or they have impaired inner or outer retinal 
photoreception. Although Glickman et. (2006) did not quantify the melanopic lux of blue 
light used to treat depression in SAD, it is shown that blue light was as effective as white 
light compared to red light. The photoreceptor pathway that broadband bright white light and 
blue light trigger depression treatment in SAD is yet to be understood. Nevertheless, the 
lower melanopsin sensitivity in patients with SAD (Roecklein et al., 2013) and the success of 
light therapy with short wavelength (blue) light (Glickman et al., 2006) with high melanopic 
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excitation are suggestive that ipRGCs are contributing to the pathological mechanisms of 
depression in SAD. The contribution of ipRGCs to non-seasonal depressive disorder and its 
relationship to environmental light exposure remains to be determined and will be an aim of 
this thesis.  
There is evidence suggesting a role of ipRGCs in the outer retinal photoreceptors-
mediating image-forming functions via the intraretinal dopaminergic system (Joo et al., 2013; 
Prigge et al., 2016). The image-forming functions  of ipRGCs are thought to be driven via the 
retrograde projection of the axons of ipRGC to the outer retina through the dopaminergic 
system (Joo et al., 2013; Prigge et al., 2016).  The next section  reviews the current literature 
on the image-forming retinal functions in depressive disorder. 
2.5 RETINAL FUNCTION IN DEPRESSIVE DISORDERS  
Electroretinogram (ERG) has been widely used to measure the electrical responses 
from rod and cone in the outer retina and bipolar, muller and amacrine cells in the inner 
retina. (Hamel, 2007; Miller & Dowling, 1970; Wachtmeister & Dowling, 1978). A typical 
ERG response consists of a, b, c, d waves and oscillatory potentials origination from rod-
cone, ON bipolar and muller cells, pigment epithelium, OFF bipolar cells and amacrine cells 
respectively (Hamel, 2007; Marmor & Hock, 1982; Wachtmeister et al., 1978). A recent 
study optimized stimuli to match the ipRGC spectral sensitivity and showed that  ERG 
response can be elicited from ipRGCs (Kuze, Morita, Fukuda, Kondo, Tsubota, & Ayaki, 
2016).  
Most studies report lowered retinal sensitivity in patients with SAD than healthy 
controls. While one study suggests there is no change in retinal sensitivity in SAD (Oren, 
Moul, Schwartz, Alexander, Yatnada, & Rosenthal, 1993), Hebert et al., (2002, 2004) report 
a seasonal variation in retinal sensitivity in humans with lower retinal sensitivity occurring 
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during winter (Hébert et al., 2004; Hébert et al., 2002). Indeed, lower electroretinogram 
(ERG) b-wave amplitudes are reported in the patients with SAD compared to the normal 
controls (Hébert et al., 2004; Hebert, Dumont, & Lachapelle, 2002). There is also a positive 
correlation between the severity of seasonal mood changes and the ERG b-wave amplitude 
(Hebert et al., 2002) in SAD. A reduction in ERG amplitude in SAD is an indicative of 
impaired dopaminergic and serotonin (monoamines) neurotransmission in the retina and 
central nervous system (Hébert et al., 2004; Lavoie, Illiano, Sotnikova, Gainetdinov, 
Beaulieu, & Hébert, 2014). 
Several other studies have proposed retinal hypersensitivity in SAD on ophthalmic 
measures of visual function (Oren, Joseph-Vanderpool, & Rosenthal, 1991; Terman & 
Terman, 1999; Wesner et al., 2006). The patients with SAD adapt more rapidly in dark than 
the healthy controls (Oren et al., 1991). In addition, the patients with SAD have higher 
photopic contrast sensitivities (CS) (Wesner et al., 2006) than the healthy people. The 
scotopic (rod) and photopic (cone) thresholds in an incremental detection task are lower in 
summer than in winter (Terman et al., 1999) and the thresholds are lower in the patients with 
SAD than in  healthy individuals in winter indicating that rod and cone pathways may be 
supersensitive in the patients with SAD (Terman et al., 1999). This indicates outer retinal 
photoreceptor sensitivity varies with season with higher sensitivity in summer than in winter 
and in particular rod and cone pathway sensitivities in the patients with SAD are higher than 
in healthy individuals in winter.   
Similar to the patients with SAD, there are mixed findings as to the effect of non-
seasonal depression on visual function. While Wesner and Tan, (2006) observed increased 
contrast sensitivity (CS) in non-seasonal depression measured using Gabor stimuli modulated 
at higher spatial (12 cpd) and low temporal frequencies (2 Hz with Gabor target of 4 cpd), 
Fam et al, (2013) demonstrated a reduction in contrast sensitivity measured with the Freiburg 
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visual acuity and contrast test (FrACT) compared to healthy control participants (Fam et al., 
2013). However, there was no difference in the mean pattern ERG (PERG) and full field 
ERG (ffERG) amplitudes among both groups (Fam et al., 2013). The PERG amplitude was 
significantly reduced in the patients with depression compared to the controls, with the 
reduction being strongly correlated with the depression severity, but independent of the anti-
depressive medication (Bubl et al., 2010; Bubl et al., 2015). Bubl et al. (2015) further showed 
that the VEP amplitude, a measure of visual cortical response, was reduced, but not to the 
extent as the PERG based contrast amplitude reduction in major depression, indicating that 
visual cortex in depression is affected and is preceded by the reduction in retinal contrast 
sensitivity. Another study demonstrated a significant reduction in contrast sensitivity in MDD 
and bipolar disorder patients when measured with 2 cpd Gabor targets, with the reduction 
being independent of the severity and anti-depressive medication (Bubl et al., 2009). While, 
methodological variations might have shown inconsistent visual contrast sensitivity findings, 
depressive disorders have been most strongly associated with a reduction in visual contrast 
sensitivity. This suggests, like SAD, people with non-seasonal depression also may have an 
impaired intra-retinal dopaminergic system, analogous to Parkinson’s disease (Harnois & Di 
Paolo, 1990; Ikeda, Head, & Ellis, 1994), which is associated with reduced visual contrast 
sensitivity (Bodis-Wollner, Marx, Mitra, Bobak, Mylin, & Yahr, 1987; Ikeda et al., 1994; 
Price, Feldman, Adelberg, & Kayne, 1992) that is improved following administration of  
dopamine (Büttner, Kuhn, Patzold, & Przuntek, 1994). Hence, this study will also determine 
the retinal visual function by measuring visual contrast sensitivity using conventional 
ophthalmic charts. 
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2.6 EXPERIMENTAL AIMS AND HYPOTHESIS  
This study compares intrinsically photosensitive Retinal Ganglion Cell (ipRGC) 
function and outer retinal function in patients with non-seasonal depressive disorder to a 
healthy age-matched control group. The pupil light reflex is used as an objective and non-
invasive biomarker of inner and outer retinal function; melanopsin function is isolated using 
the ipRGC-mediated post-illumination pupil response (PIPR) and outer retinal function is 
determined from the peak pupil constriction (peak PLR), transient pupil constriction 
(transient PLR) and time to peak constriction amplitudes (time to peak PLR). Outer retinal, 
cone-pathway mediated visual function is determined using a Pelli-Robson contrast 
sensitivity charts (Pelli & Robson, 1988). Ambient light exposure is quantified using 
Actigraphy in terms of the average day and night light exposure (per minute, per hour) and 
time spent daily under bright light levels (≥ 2500 lux, ≥ 5000 lux and ≥ 10,000 lux) in 
patients with depression and age-matched controls. The aims and hypotheses of the study are 
as follows:  
Aim 1  
To quantify the relationship between the post-illumination pupil response (PIPR), transient 
and peak pupil constriction amplitude, time to peak constriction amplitude and the ambient 
environmental light exposure in individuals with and without non-seasonal depression. It is 
hypothesised that the PIPR and PLR amplitudes will be lower in patients with non-seasonal 
depression than in healthy control participants. The ambient daylight exposure levels are 
predicted to be lower in patients with non-seasonal depression compared to the healthy 
control participants. The PIPR and PLR amplitudes will positively correlate with the light 
exposure levels among the patients with depression. 
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Aim 2 
To determine the visual contrast sensitivity in individuals with and without non-seasonal 
depression. It is hypothesised that the patients with depression will have lower contrast 
sensitivity scores than the healthy control participants. Reduction in contrast sensitivity will 
positively correlate with the transient PLR among the patients with depression.   
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CHAPTER 3: EXPERIMENTAL METHODS 
3.1 ETHICS STATEMENT 
All procedures were approved by the QUT Human Research Ethics Committee 
(Approval Number: 1500000597) and followed the Declaration of Helsinki. All participants 
signed an informed consent before participation.   
3. 2 PARTICIPANTS  
Participants consisted of two groups; participants with non-seasonal depression 
(depression group) and healthy individuals without depression (control group). All 
participants in the depression group were taking medications for depression, including 
selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake 
inhibitors (SNRIs), monoamine oxidase inhibitors (MAOI), agomelatine, and antimanic 
drugs. A summary of the inclusion criteria for the two groups and the assessment procedures 
is provided in Table 1. The depression group was required to have (i) current Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) MDD assessed using the Mini 
International Neuropsychiatric Interview (MINI), version 6.0.0, (ii) at least mild levels of 
depressive symptoms in the last 2 weeks on the Beck Depression Inventory-II and (iii) a 
negative screen on both clinician-rated and self-report measures of SAD (winter depression), 
including the Hamilton Depression Rating Scale-Seasonal Affective Disorder (HDRS-SAD) 
and the Seasonal Pattern Assessment Questionnaire (SPAQ). The HDRS-SAD and SPAQ 
were administered to the participants who had recurrent depression on the MINI. Those with 
recurrent MDD with at least two depressive episodes during the winter in the past two 
consecutive years with remission in the summer were identified as meeting the DSM-IV 
criteria of SAD. People with self-reported history of a psychotic or bipolar disorders were 
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excluded. The presence of bipolar and psychotic disorders was also confirmed with MINI 6. 
People with a cognitive impairment and/or intellectual disability were also excluded as they 
were unlikely to understand the purpose of the research in order to provide informed consent. 
The healthy control group was required to have a negative screening on all measures of 
depressive symptoms and disorders and no lifetime history of depression.  
On the ophthalmic assessment (Table 1), all participants had a best corrected visual 
acuity (BCVA) better than 6/6, normal colour vision, no previous intraocular surgery, no 
ocular disease and no diabetes. All participants had a colour vision examination with a 
L’anthony D-15 test, slit-lamp examination, anterior chamber angle assessment, a pupillary 
light reflex screen with a torchlight, indirect ophthalmoscopy and optical coherence 
tomography (OCT) (Nidek RS-3000 OCT Retiscan Advanced, NIDEK CO., LTD) to detect 
any ocular pathology. 
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Table 1: Study inclusion criteria and assessment procedures   
Examination Instrument Inclusion criteria (Non-seasonal 
depression) 
Inclusion criteria 
(healthy controls) 
Psychology MINI MDD (Current) and no psychotic 
and bipolar disorder 
No MDD and 
No psychotic and bipolar 
disorder 
 HDRS-SAD Recurrent depressive episodes 
(MINI) with score of > 19 on the 
HDRS and ≤ 4 on the atypical 
subscale  
A score of < 19 on the 
HDRS and ≤ 4 on the 
atypical subscale 
 BDI-II 
SPAQ 
Score > 10 
Recurrent depressive episodes 
(MINI) with GSS < 11, not feeling 
worst in  the winter months (June, 
July and August)  
Score < 9 
GSS < 11, not feeling 
worst in the winter 
months (June, July and 
August) 
Cognition Observation No intellectual disability and 
cognitive impairment 
No intellectual disability 
and cognitive impairment 
Visual Acuity Bailey-Lovie Log 
MAR Chart 
6/6 
Colour Vision L’anthony 
Desaturated Panel 
D-15 test for 
colour vision 
Normal colour vision 
Ophthalmoscopy Binocular Direct 
Biomicroscopy (90 
D/78D lenses) 
Normal retina and optic disc 
IOP I-Care Tonometer ≤  21 mmHg 
Ocular Media Nikon Slit Lamp 
Biomicroscope 
No corneal and lenticular opacities 
Macula and 
Optic Disc 
Optical Coherence 
Tomography 
(OCT) 
Normal macular and RFNL thickness 
BDI-II, Beck Depression Inventory, 2nd edition; GSS, Global Seasonality Score; HDRS-SAD, 
Hamilton Depression Rating Scale -Seasonal Affective Disorder; MINI, Mini International 
Neuropsychiatric Interview; SPAQ, Seasonal Pattern Assessment Questionnaire;  
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In accordance with the human research ethics approval (Approval Number: 
1500000597), patients with depression were approached and recruited from the Queensland 
University of Technology (QUT) Psychology and Counselling, Health clinic and General 
practices, two private psychology clinics in Brisbane (Psychology Consultants), depression 
support groups around the Brisbane central business district and via newspaper 
advertisements. Advertisements were distributed via flyers, student emails and word of 
mouth within QUT to recruit both the depression group and age and gender matched healthy 
controls. Psychologists were provided with the study details and flyers to distribute to the 
potential participants with depression. They were followed up and reminded through regular 
meetings, emails and telephone contacts. Figure 8 displays the study protocol.  
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Figure 8: The study protocol. 
The study consisted of 2 visits. During the 1st visit (Blue), participants provided informed 
consent and were screened for ocular and mental health and received a Geneactive device 
(Actigraph). During the 2nd visit (green), participants underwent the pupillometry (see text for 
detail). 
3.3 ACTIGRAPHY 
All participants were provided with a light sensor watch (Geneactive, Activinsights, 
Kimbolton, Cambridgeshire, UK) for 2 weeks from the months November 2015 through 
August 2016 in Brisbane, Australia (27.5° S, 153.0° E). They were instructed to wear the 
device on the non-dominant wrist continuously during the 2 weeks to determine the daily 
light exposure and sleep-wake timings and duration. Each participant was asked to maintain a 
log of bedtime, time to sleep after going to bed, number of times awake after bed, maximum 
number of minutes awake after going to the bed (between sleep), final wake time, number of 
day naps and maximum number of hours of day naps. After two weeks of the wear, the raw 
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data were extracted and imported to an Excel spreadsheet sleep macro constructed by 
Activinsights (Kimbolton, Cambridgeshire, UK) that allows interpreting the sleep-wake 
timings, sleep length, mid-sleep time, Geneactive wear times and minutes of light exposure 
(lux). The mid-sleep time was computed to compare the circadian phase and chronotype 
between the MDD and control groups (Martin & Eastman, 2002; Terman, Terman, Lo, & 
Cooper, 2001; Zavada, Gordijn, Beersma, Daan, & Roenneberg, 2005). Using the macro 
spreadsheet, the minutes and hours of day and night light exposure (lux) for 14 days (20,160 
min) and light exposure duration to broadband light  (≥ 10,000 lux, ≥ 5000 lux, ≥ 2500 lux) 
that are the illuminance ranges recommended for depression light therapy (Even et al., 2008; 
Gallin et al., 1995; Glickman et al., 2006; Haffmans et al., 2008; Kräuchi et al., 1990; 
Meesters et al., 2011; Naus et al., 2013; Szabó et al., 2004; Winkler et al., 2005; Wirz-Justice 
et al., 1999) were computed. To account for the differences in light exposure due to different 
wake times among the participants, circadian time was normalized to individual wake time. 
Sleep length and sleep efficiency were derived from the sleep macro and sleep onset latency 
(time to sleep after going to bed) was derived from the participants’ self-reported sleep 
charts. 
The time to first light, last light and the global solar exposure (GSE) of Brisbane, 
Australia were recorded for every day for each participant from the websites of the 
WillyWeather and Australian Government, Bureau of Meteorology, respectively (Australian 
Government, 2016; WillyWeather, 2016).  Light exposure artefacts were excluded. Artefacts 
were determined by light exposure data generated over non-wear times of the Geneactive 
device and the data indicating complete darkness with activity during the day when the 
person was not in bed. Artefacts could occur by participants not wearing the watch and by 
their clothes covering the light sensors. However, artefacts were minimized at best by 
instructing the participants not to remove the watch or cover the light sensor with clothing 
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throughout the study period. The participants were also followed up for the compliance at the 
final visit.  
3.4 PSYCHOLOGICAL ASSESSMENTS FOR DEPRESSION  
3.4.1 MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW  
The MINI 6 was used to assess for the presence of 12-month DSM-IV diagnosis of 
depression and anxiety disorders. (Lecrubier, Sheehan, Hergueta, & Weiller, 1998). It is a 
brief diagnostic structured interview [average time to administer = 16.4 min (Pinninti, 
Madison, Musser, & Rissmiller, 2003)] which can be easily administered by non-specialized 
interviewers. The Mini has been validated against the Composite International Diagnostic 
Interview (CIDI) and the Structured Clinical Interview for DSM-IH-R (SCID) to assess for 
the presence of 17 disorders based on DSM-IV diagnostic criteria (Lecrubier, Sheehan, 
Weiller, Amorim, Bonora, Harnett Sheehan, Janavs, & Dunbar, 1997). It contains a 
suicidality section that assesses whether the individual has ‘seriously thought about 
committing suicide’ (suicidal ideation), ‘made a plan for committing suicide’ (suicide plan) 
and ‘attempted suicide’ (suicide attempt) in their ‘lifetime’ and ‘within the past month’. A 
score of 1-8 indicates they are at low risk, 9-16 points indicated moderate risk and > 17 
points indicates high risk. Participants with high suicidal risk as assessed with MINI were not 
included in the study.  
3.4.2 THE BECK DEPRESSION INVENTORY-II (BDI-II)  
The Beck Depression Inventory-II (BDI-II) is a 21-items self-report measure of the 
severity of depression symptoms (Beck, Steer, Ball, & Ranieri, 1996). BDI-II has been 
validated in 414 students showing high internal consistency and validity (Storch, Roberti, & 
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Roth, 2004). Each question is rated on a 4-point scale that ranged from 0 = no depression 
symptom to 3 = obvious depression symptom to derive a total score indicative of depression 
severity (See Table 2 for interpretation). 
 
Table 2: BDI-II scores and depression Severity 
BDI-II Scores Severity of Depression 
0-9 Normal 
10-16 Mild Depression 
17-29 Moderate Depression 
30-63 Severe Depression 
BDI-II, Beck Depression Inventory, 2nd edition 
3.4.3 SEASONAL AFFECTIVE DISORDERS 
Those participants who met criteria for recurrent depression on the MINI 6 (recurrent 
MDD with at least two depressive episodes during winter in the past two consecutive years 
with remission in the summer) completed both clinician-rated and self-report measures of 
SAD to exclude patients with SAD. 
3.4.3.1 THE HAMILTON DEPRESSION RATING SCALE -SEASONAL 
AFFECTIVE DISORDER VERSION (HDRS-SAD)  
The HDRS-SAD consists of two clinician-rated scales: the 21-item Hamilton 
Depression Rating Scale (HDRS) and 8-item atypical features of SAD (ATYP) scale 
(Williams, Link, Rosenthal, & Terman, 1988). A score of at least 19 on HDRS and a score of 
4 or more on the 8 ATYP symptom score was indicative of SAD (Terman, Terman, & 
Rafferty, 1990). The inter-rater reliability trial of HDRS-SAD shows relatively low inter-rater 
discrepancy (5.6%), specially with items- “”depressed mood”, “work and activities”, “middle 
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insomnia”, and “hypochondriasis” and atypical (SAD) items- “fatigability” and 
“Hypersomnia” (Rohan, Rough, Evans, Ho, Meyerhoff, Roberts, & Vacek, 2016). Given, 
some degree of discrepancy recorded with HDRS-SAD, the diagnosis of MDD and SAD will 
be made in conjunction with MINI, BDI-II and SPAQ that are shown to have high internal 
consistencies (Lecrubier et al., 1997; Magnusson, Friis, & Opjordsmoen, 1997; Storch et al., 
2004).  
3.4.3.2 THE SEASONAL PATTERN ASSESSMENT QUESTIONNAIRE 
(SPAQ) 
The self-report SPAQ assesses the degree of seasonal variations of mood and behaviour 
on six items including mood, sleep duration, social activities, weight, appetite and energy 
rated on a 4-point scale (no change = 0 to extremely marked change = 4). A global 
seasonality score (GSS) of  > 11 is indicative of SAD, and requires individuals to “feel 
worst” in winter (July and/or August), compared to summer (January and/or February) and to 
experience at least moderate problems with season change (Kasper, Wehr, Bartko, Gaist, & 
Rosenthal, 1989). 
The participant’s level of distress was also monitored throughout the study procedure 
(as indicated by voice tone/affect/self-reported mood). Participants were directly asked “are 
you feeling ok?” if they were feeling any distress at the end of the study experiment. Any 
participant reporting distress was debriefed by using a debriefing protocol (Appendix 9.0). 
3.5 PUPILLOMETRY 
The PLR and PIPR were measured with an extended Maxwellian view open-loop  
pupillometer that was custom-built and calibrated for wavelength and irradiance in the 
Medical Retina Laboratory at the Institute of Health and Biomedical Innovation (IHBI), QUT 
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(Adhikari et al., 2015b; Feigl et al., 2014). The pupillometer consists of narrow band light-
emitting diode (LED) light sources (Figure 9) projected in the pupil plane of the left eye via 
two Fresnel lenses (100 mm diameter, 127mm and 70 mm focal lengths respectively, 
Edmund Optics, Singapore) and a 5° light-shaping diffuser (Physical optics Corp., Torrance, 
CA, USA) (Adhikari et al., 2015b).  
 
 
 
 
Figure 9: The Maxwellian view open-loop pupillometer system 
A Maxwellian view pupillometer system consists of an LED light source placed in a rotating 
wheel positioned in the focal plane of the 1st Fresnel lens (F1). The LED projects a divergent 
beam to F1 which produces a parallel beam after refraction and projects to the 2nd Fresnel lens 
(F2) which is positioned such that rays after refraction from (F2) focuses on the pupil plane of 
the left eye. The infrared (IR) LED illuminates the right eye via reflection through two 
parallel mirrors (M). The camera (C) records the pupil light reflex of the right eye. An 
aperture (A) is placed at the focal planes of F1 and F2 which controls the field of view of the 
system. 
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The left pupil was dilated with 0.5% Tropicamide (Minims; Chauvin Pharmaceuticals 
Ltd., Romford, UK). The participant was dark adapted for 10 minutes in a darkened 
laboratory (< 1 lux) and the consensual pupil light reflex in the right eye was recorded under 
an infrared LED illumination (851 nm). A custom developed Matlab software (version 
7.12.0; Mathworks, Nitick, MA, USA) was used to control the stimulus presentation and 
analyse the pupil light reflex. The pupillometry procedure was done between 10 AM to 5 PM 
to minimize the effect of circadian variation of the PIPR amplitude in humans (Münch et al., 
2012; Zele et al., 2011).  
In accordance with standard procedures developed and validated in the Medical Retina 
Laboratory (Adhikari et al., 2015b; Adhikari et al., 2016b), the pupil light reflex was 
measured under high melanopsin and low melanopsin excitation conditions. The high 
melanopsin excitation stimulus included a narrow-band blue appearing light (464 nm) with 
20 nm band-width at half maximum, 2.9 log cd.m-2 luminance, 15.5 log quanta.cm-2.s-1 
corneal irradiance and 8601.7 α-opic lux (Lucas, Peirson, Berson, Brown, Cooper, Czeisler, 
Figueiro, Gamlin, Lockley, O’Hagan, Price, Provencio, Skene, & Brainard, 2014). The low 
melanopsin excitation control stimulus was narrow-band red appearing light (637 nm) with 
22 nm band-width at half maximum, 3.1 log cd.m-2 luminance, 15.5 log quanta.cm-2.s-1 
corneal irradiance and 0.5 α-opic lux. The red light stimulus (637 nm) was used to determine 
the outer retinal photoreceptor contribution to PLR and control fatigue in PIPR (Gamlin et al., 
2007; Kankipati et al., 2010; Markwell et al., 2010; Zele et al., 2011). The measurement for 
each wavelength was repeated twice with an interval minimum of ~ 2 minutes between 
stimuli so that the sustained PIPR of the first recording did not affect the subsequent 
recordings (Adhikari et al., 2015b). The stimuli were alternately presented to account for the 
effect of melanopsin bistability (Mure, Rieux, Hattar, & Cooper, 2007). Figure 10 shows the 
pupillometry protocol of stimuli presentation and recording. 
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Figure 10: The pupillometry protocol used in the experiment 
Following 10 mins of dark adaptation (black) to the laboratory illumination (< 1 lux), the 
baseline pupil diameter was recorded for 10 s (gray) which was followed by the pupil 
recording with a 1 s long wavelength light (red) stimulus. The post-illumination pupil 
recording was done for 40 s after light offset (gray). The procedure was repeated for the short 
wavelength light (blue) stimulus after 2 mins break in dark. Two repeats for each of the red 
and blue light stimulus were recorded with 2 mins break between the repeats.  
 Two PIPR metrics were quantified: the 6 s PIPR and the plateau PIPR amplitudes. The 
net PIPR (Kankipati et al., 2010; Roecklein et al., 2013) was not reported because it has both 
higher intra- and inter-individual variation than the plateau and 6-second metrics (Adhikari et 
al., 2015b). The maximum pupil constriction (PLR), transient PLR and time to peak 
constriction in response to short (blue) and long (red) wavelength stimuli were analysed for 
all participants. Custom developed Matlab software (version 7.12.0; Mathworks, Nitick, Ma, 
USA) was used to control the stimulus presentation, analyse the pupil light reflex metrics and 
linearly interpolate the missing data points due to blinks.  
3.5.1 PUPILLOMETER CALIBRATIONS 
The spectroradiometric calibrations were performed for the red and blue LEDs. The 
spectral outputs of the LEDs were measured with a spectroradiometer (StellarNet, Tampa, 
FL, USA) positioned in the optical system at the position of the eye. The spectral output 
normalized to the peak irradiance for blue and red LEDs is shown in Figure 11.  
50 
 
3 5 0 4 0 0 4 5 0 5 0 0 5 5 0 6 0 0 6 5 0 7 0 0 7 5 0
0 .0
0 .2
0 .4
0 .6
0 .8
1 .0
N
o
rm
a
li
s
e
d
 I
rr
a
d
ia
n
c
e
 (
W
a
tt
s
.c
m
-
2
. s
-
1
)
W a v e le n g th  (n m )
max = 4 6 4 n m 6 5 8 n mmax =
 
Figure 11: The spectral output of the LEDS used in the pupillometer.  
The spectral output calibration of blue (max = 464 nm) and red (max = 658 nm) 
normalized to their peak irradiance are shown.  
The irradiance of the LEDs was measured with a calibrated ILT 1700 Research 
Radiometer (International light technologies, Inc., Peabody, MA, USA) (Nygaard & 
Frumkes, 1982) at the plane of the artificial pupil which gave a representation of actual eye 
position during the pupillometry procedure. Calibrations were done in a dark room 10 mins 
after turning on the radiometer. The radiometer was first set at zero to the dark light. The 
irradiance levels were controlled by adjusting the 8-bit Digital to Analogue Converter (DAC) 
values using Matlab software manually. The DAC value ranges from 0 (minimum) to 225 
(maximum).  The measurement was done by varying the DAC values from 1 to 225 in both 
ascending and descending order for both wavelengths. The corresponding radiometer 
readings (irradiance) were measured and 3 measurements were averaged for each DAC value.  
A linear trendline was fitted to the irradiance as a function of DAC values (Figure 12) were 
calculated for required irradiance levels using the following equation: 
Y = mx + c                (Equation 1) 
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Where  
Y = irradiance, x = DAC value, m = slope of the trendline, c = intercept of the trendline to the 
y-axis. 
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Figure 12: The irradiance output calibration of the red and blue LEDs.  
The irradiance output (watts.cm-2) as a function of DAC values for short wavelength (blue) 
and long wavelength (red) stimuli LEDs.  
Radiometric unit of power (watts. cm-2.s-1) was converted to an actinometric unit of 
quanta (log quanta.cm-2.s-1) by following the relationships explained below. 
The relationship between quanta (Φ) and radiant power (φ) is given by  
Φ = φ*hc                (Equation 2) 
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Where is the wavelength in meters, h is the planks constant (6.626 x 10-34) and c is the 
speed of light (2.998 x 108 m/s). For a point light source, quanta flux (quanta/s) and radiant 
power (Watts) are related to irradiance (Watts/m2) and quanta irradiance (quanta/m2/s) by 
φ = ER*A and 
Φ = Eq*hc 
Where ER is irradiance, Eq is quanta irradiance and A is the area of the surface that receives 
light. By combining the above equations,  
ER = Eq *hc                (Equation 3) 
3.5.2 PUPILLOMETRY DATA ANALYSIS 
The pupil light reflex data were fitted with linear and exponential models (Feigl et al., 
2011; Zele et al., 2011). The first 10 s pre-stimulus phase, defined as the baseline pupil 
diameter (BPD) which was fitted with a constant. The second phase started with the light 
onset reaching up to the maximum constriction (PLR) from where the pupil partially redilated 
and plateaued to give rise to the PIPR. This PIPR phase that started at stimulus offset was 
fitted with an exponential model described by the following equation, by minimising the 
sums of square differences in Microsoft Excel 2010 (Microsoft Corporation) using the Solver 
analysis tool:  
y = S * Exp (k * x) + P                   (Equation 4) 
Where S is a constant, k is the pupil redilation velocity (Global rate constant; GR) in mm/s, x 
is time in second, and P is the plateau of the PIPR in mm (Feigl et al., 2011). The 6 s PIPR 
amplitude was determined as the pupil diameter at 6 s after light offset on the exponential 
model fitted to the PIPR phase. The PLR and PIPR amplitudes were normalized to the dark-
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adapted baseline pupil diameter to account for the differences that would occur due to 
differences in baseline pupil diameter. 
3.6 CONTRAST SENSITIVITY  
Contrast sensitivity (CS) was measured in all participants with a wall mount Pelli-
Robson chart (Clement Clarke International Ltd.) (Pelli et al., 1988). The Pelli-Robson chart 
is a 90 x 60 cm chart that consists of 8 rows of letters with different contrast. Each row 
consists of 6 letters with 3 letters (triplet) on the left with higher contrast than the triplet on 
the right. The contrast decreases downwards and towards the right. The highest left triplet 
letters have the highest contrast (1 or 100%) and the lowest right triplet letters have the 
lowest contrast (0.006 or 0.6%). All letters in the chart are of equal size, subtending 1 cycle 
per degree (cpd) at the recommended testing distance of 1 m (Pelli et al., 1988). Photopic 
contrast sensitivity was tested in the left eye for all participants. The chart illuminance on 
average was 450 lux. The contrast sensitivity score was recorded for the last triplet of which 
at least 2 letters were correctly reported in accordance with the triplet scoring procedure 
suggested by Pelli et al, (1988). Contrast sensitivity was recorded as log contrast sensitivity 
(Log CS). 
3.7 SAMPLE SIZE CALCULATIONS AND POWER ANALYSIS 
Sample size calculation was done based on the means and standard deviations of a 
recent SAD study that showed significant results in the PIPR amplitude in a sample of 15 
participants (Roecklein et al., 2013). A minimum of 45 participants was calculated to detect a 
significant difference in the PIPR with an effect size of 0.70 and power of 0.95 at a 
significance level of 0.05.  
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3.8 STATISTICAL ANALYSIS  
Statistical data analysis was done with IBM SPSS 22 and GraphPad Prism (GraphPad 
Software, Inc., CA, USA). Prior to the data analysis, the data were screened to assess the 
assumptions for parametric testing.  Light exposure, quantified in terms of the average day 
and night light, hourly light exposure and number of minutes of light exposure derived from 
the Geneactive macro, and the PLR (peak constriction amplitude, transient PLR and time to 
peak constriction) and the PIPR (6 s and plateau PIPR) metrics were tested for normality 
using Shapiro-Wilk test. Independent t-test (for parametric distribution) and Mann-Whitney 
test (for non-parametric distribution) were used to determine the difference in daily light 
exposure between the groups. Mean and SD were reported for parametric data and median 
values were presented for non-parametric data. The effect of medications on the PLR and 
PIPR was analysed by comparing these parameters separately for each medication between 
patients taking the medication and healthy controls. Hourly light exposure (lux) values were 
log transformed to fulfil the assumption of parametric tests. A factorial univariate one-way 
ANOVA was used to analyse the interaction of hourly light exposure among the groups for 
time of the day and seasons. Pearson’s (for parametric data) and Spearman’s (for non-
parametric data) correlation coefficients were calculated to analyse the effects of PIPR on 
sleep parameters and depression severity and the effect of seasonal variation in light levels on 
the daily exposure levels within the groups. The analysis of covariance was done for gender, 
photoperiod and GSE to eliminate the potential effect of these factors on the light exposure 
and PIPR amplitude. The effect of depression severity on the visual contrast sensitivity was 
analysed with a linear regression model. The statistical significance was determined based on 
whether or not the slope of the best-fitting linear regression line was significantly different 
from zero using an F-test (95% confidence interval, p < 0.05). 
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CHAPTER 4: RESULTS  
 4.1 PARTICIPANT CHARACTERISTICS 
All participants were recruited during the months November 2015 to August 2016. 
Based on the season, the recruitment period was classified as summer dominating months 
(Nov-Mar) or winter dominating months (Apr-Aug). A total of 22 participants was recruited. 
Thirteen participants were recruited during the summer dominating months (depression, n = 
4; control, n = 9) and nine during the winter dominating months (depression, n = 4; control, n 
= 5). A total of 14 patients with depression were referred for participation in the study. Of 
these 14 patients, six were excluded as two patients had glaucoma, two had a history of 
psychosis and two did not have a current major depressive disorder (MDD) on the MINI. 
Table 3 shows the characteristics of the patients with depression.  
Table 3: The characteristics of the patients with non-seasonal depression  
SN Sex Age 
(Y) 
MDD Diagnosis* Diagnosis 
Duration  
Episode Severity** 
1 F 23 Current MDD 2 years 1 Moderate 
2 F 34 Current MDD 3 years 1 Moderate 
3 M 39 Current MDD with panic 
disorder lifetime with 
agoraphobia and social phobia 
3 years 2 Severe 
4 F 18 Current MDD with panic 
disorder lifetime with 
agoraphobia 
1 Year 1 Moderate 
5 F 36 Current MDD 21 years 1 Severe 
6 F 57 Current MDD with panic 
disorder lifetime with 
agoraphobia and social phobia 
21 Years 1 Mild 
7 F 61 Current MDD with post-
traumatic stress disorder  
18 Years 2 Moderate 
8 F 32 Current MDD with panic 
disorder lifetime without 
agoraphobia  
2 Years 2 Moderate 
MDD, major depressive disorder 
*Diagnosis based on the Mini International Neuropsychiatric Interview, Version 6 (MINI 6) 
**Severity based on the Beck Depression Inventory, Version II  
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A total of 16 control subjects with a negative screen for a current depressive disorder were 
recruited. Two control subjects with family history of depression were excluded. One female 
control participant was excluded from the pupillometry analysis as she was unable to 
maintain her eye wide open during the procedure such that the pupil margins were not 
tracked by the Matlab software. This resulted in eight patients (7 females /1 male, median age 
= 35 years) with depression and 14 healthy controls (7 females / 7 males, median age = 29 
years) for light exposure analysis and 13 controls (6 females / 7 males, median age = 29 
years) for pupillometry analysis. The time at which pupillometry procedure was done 
between the groups were not significantly different (p = 0.47). The groups did not differ in 
age (p > 0.05, Mann-Whitney test). The current study has a higher proportion of females 
(87.5%) than the general female estimates among the Australian population with depression 
(63.6%) (Wilhelm, Mitchell, Slade, Brownhill, & Andrews, 2003). The proportion is 
consistent with the recent studies with patients with SAD (86.8%) (Roecklein et al., 2013) 
and MDD including SAD (79%) (Laurenzo et al., 2016).  There was no significant group 
effect of the gender on the pupil and light exposure measures (p > 0.05, Mann-Whitney test). 
There was also no significant difference in PIPR amplitude (F 1,16 = 0.6, p = 0.4) and mean 
daylight exposure (F 1,16 = 0.8, p = 0.4) between the groups when gender was analysed for a 
covariate. 
The mean BDI-II scores were 25.8 ± 5.7. Although three patients with depression met 
MINI criteria for recurrent depression and had HDRS-SAD atypical scores above the clinical 
cutoff for SAD, these patients were not excluded from study as they did not have winter 
depression with worst mood during the winter months on the SPAQ. Their GSS was also 
below the clinical cut for SAD on the SPAQ (see Table 4).  
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Table 4: Depression scores on SAD measures in patients with recurrent depressive episodes on 
the MINI 
SN MINI No. of 
episodes 
(n = 8) 
HDRS (21 
item) 
(n = 3) 
HDRS-SAD 
(Atyp) 
(n = 3) 
SPAQ 
(GSS) 
(n = 3) 
(SPAQ) 
winter worst 
(n = 3) 
1 1     
2 1     
3 2 23 10 3 NO 
4 1     
5 1     
6 1     
7 2 10 6 3 NO 
8 2 9 8 9 NO 
GSS, global seasonality score; HDRS-SAD, Hamilton depression rating scale for seasonal affective 
disorder; MINI, Mini international neuropsychiatric interview; SPAQ, Seasonal pattern assessment 
questionnaire  
All patients with depression were on psychotropic medication for depression. The 
patients with depression had current treatment with selective serotonin reuptake inhibitors 
(SSRIs) (87.5%) and/or combined with norepinephrine reuptake inhibitors (SNRIs) (25%), 
monoamine oxidase inhibitors (MAOI) (12.5%), agomelatine (12.5%), anticholinergic 
(Nortriptyline) (12.5%) and antimanic (25%) drugs. Although two patients with depression 
were taking antimanic drugs (Lithium carbonate) as mood stabilizers, they neither had self- 
report history of bipolar disorder nor were assessed as bipolar disorder in the MINI. One 
female participant in the depression group was taking hormonal contraceptive and one was 
under hormonal therapy for thyroid dysfunction. None of the control participants were taking 
any medication during the study. As most of the patients with depression in the study were 
taking SSRIs and mixed reports of their effect on the resting pupil diameter (increased or 
decreased baseline pupil diameter) have been reported (Bitsios, Szabadi, & Bradshaw, 1999; 
Phillips, Bitsios, Szabadi, & Bradshaw, 2000; Schmitt, Riedel, Vuurman, Kruizinga, & 
Ramaekers, 2002), the PLR and PIPR data of the patients were normalized to their individual 
dark adapted baseline to nullify the effect of the differences in the resting pupil diameters. 
The antidepressants of the class SNRI are expected to affect the baseline pupil diameter, 
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pupil constriction amplitude and time to pupil recovery after stimulus offset (Bitsios et al., 
1999; Phillips et al., 2000; Siepmann, Ziemssen, Mueck-Weymann, Kirch, & Siepmann, 
2007). Hence, a separate analysis was performed to examine the differences in PLR and PIPR 
between the patients with depression not taking the SNRIs (n = 6) and the control group (n = 
13) (see sections 4.2 and 4.3). Although, the effects of anticholinergic drugs on the pupil 
reflex have been reported (Bye, Clubley, Henson, Peck, Smith, & Smith, 1979; Loewenfeld 
et al., 1993), the  drug (Nortriptyline) taken by one patient in this study has been shown to 
have no effect on the resting pupil diameter and the pupil light reflex (Åsberg & Germanis, 
1972; Bye et al., 1979).  Hence, separate analysis of the effect of Nortriptyline was not 
examined. The effects of other less commonly used antidepressants (MAOI and agomelatine 
by one patient and antimanic drug by 2 patients) on the pupil are not known. Nevertheless, 
there was no effect of these medications on the main outcome parameter, the 6 s PIPR 
amplitude among the patients with depression (P < 0.000, Mann-Whitney test). 
The light exposure data were excluded as artefacts in 0.8% and 4% of the patients with 
depression and control participants, respectively. The groups did not differ in the global solar 
exposure (GSE) (p > 0.05, Mann-Whitney test) and the photoperiod (p > 0.05, independent t-
test) during the study period. There was no significant difference in PIPR amplitude 
(Photoperiod, F 1,16 = 0.5, p = 0.5, GSE, F 1,16 = 0.07, p = 0.8) and mean daylight exposure 
(Photoperiod, F 1,16 = 0.02, p = 0.9, GSE, F 1,16 = 0.1, p = 0.7) between the groups when 
photoperiod and GSE were analysed for covariates. Table 5 shows the demographic and solar 
exposure characteristics of the participants in both groups. The GSE calculated over the study 
period during the summer dominating months (median GSE = 6.1 KWh.m-2) was 
significantly higher (P < 0.000, Mann-Whitney test) than that during the winter dominating 
months (median GSE = 3.9 KWh.m-2).  
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Table 5: The demographic and solar exposure characteristics among the patients with 
depression and healthy control participants 
 Control (n = 14) Depression (n = 8) P value 
Age (y) 18-53 years (median 
age: 29) 
18-61years (median 
age: 35) 
0.129 
% Females 50 (n = 7) 87.5 (n = 7)  
Months recruited Nov-Aug Jan-Aug  
Mean (±SD) photoperiod 
(hrs) (Fig: 17) 
13.30 (1.59) 12.27 (1.13) 0.128 
Median GSE (KWh/m2) 5.10  4.41  0.258 
GSE, global solar exposure; SD, standard deviation 
4. 2 THE MELANOPSIN-MEDIATED POST-ILLUMINATION PUPIL 
RESPONSE (PIPR) 
The mean and 95% confidence limits (CL) of the pupil light reflex in response to 1 s 
short wavelength (blue) and long wavelength (red) light stimuli in patients with depression 
and healthy control participants are shown in Figure 13. The Figures indicate a similar mean 
pupil light reflex in response to red and blue light stimuli in patients with depression and the 
control group. The PIPR in response to the short wavelength blue light stimulus in the 
patients with depression, however, shows a greater variability than the control group. The 
mean pupil light reflex data ( 95% confidence limits) for the patients with depression and 
the control participants comparing the responses from two stimuli conditions are shown in 
Figure 14 and the individual data are shown in Appendix 1.0. The pupil metrics for all 
outcome parameters with short and long wavelength light stimuli in patients with depression 
and control participants are shown in Table 6. The baseline pupil diameter was not 
significantly different between the groups (depression, 6.9 ± 1.0 mm, control, 7.2 ± 0.7 mm; 
p > 0.05, independent t-test). The 6 s and the plateau PIPR amplitudes in response to blue 
stimulus were not significantly different between the groups (p > 0.05, independent t-test) 
(Figure 15) and therefore, only the 6 s PIPR data are reported as PIPR amplitude in the 
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further analysis. The linear regression of the PIPR amplitude in response to short wavelength 
blue light stimuli as a function of age among the control participants was not significantly 
different from zero, indicating that PIPR was independent of age (R2 = 0.0003, F1,11 = 
0.003.92, p = 0.95;) as previously demonstrated (Adhikari et al., 2015a; Kankipati et al., 
2010). There was no correlation between the PIPR amplitude and the BDI-II scores 
(Spearman r = 0.03, p = 0.90) among the patients with depression. Since the PIPR amplitude 
did not differ between the groups and the sample size was small for the group comparison 
with respect to season, the participants from both groups were combined to analyse the effect 
of seasons. There was no significant difference in the PIPR amplitude between the 
participants recruited during the summer and winter dominating months (p > 0.05, 
independent t-test). The linear regression line of PIPR against photoperiod in patients with 
depression and healthy controls was not significantly different from zero (R2 = 0.13, p = 0.1). 
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Figure 13: The pupil light reflex traces showing the mean pupil diameter with 95% 
confidence limits (CL) in patients with depression (n = 8) and control participants (n = 
13). 
The mean pupil diameter ± 95% CL with time (s) in response to 1 s (black rectangle) long 
wavelength (A) and short wavelength (B) light stimuli in patients with depression and control 
group. The shaded areas and the thinner lines show the 95% CL of the mean (µ) for control 
participants and patients with depression respectively. The vertical lines indicate the 6 s PIPR 
amplitude.
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Figure 14: The pupil light reflex traces showing a comparison between two stimuli 
conditions in patients with depression (n = 8) and control participants (n = 13).  
The mean pupil diameter (µ) ± 95% confidence limits (CL) with time (s) in response to 1 s 
(black rectangle) long (red) and short (blue) wavelength light stimuli in control participants 
(A) and patients with depression (B). The shaded areas and thinner red lines show the 95% 
CL of the mean (µ) for blue and red light stimuli respectively. The vertical lines indicate the 
6 s PIPR amplitude. 
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Since there was only 1 male patient with depression and there is a known higher 
prevalence of depression in females (Girgus et al., 2015), only female patients with 
depression (n = 7) were compared with the females in the control group (n = 7). There was no 
difference in the PIPR amplitude among females between the groups (p > 0.05, Mann-
Whitney test).  
Given the known effects of SNRIs on the baseline pupil diameter and the PIPR (Bitsios 
et al., 1999; Phillips et al., 2000; Siepmann et al., 2007), a separate analysis  in two patients 
with depression taking that drug showed no significant difference in  the baseline pupil 
diameter and the PIPR amplitude compared to the healthy control group (p > 0.1, Mann-
Whitney test). 
Table 6: The mean and 95% CL of the PIPR and PLR metrics (% baseline) with red and blue 
stimuli compared between the patients with depression and control participants  
Measurements                   Blue stimulus                      Red stimulus 
 Depression    Control Depression Control 
6 s PIPR 
60.31 ± 9.2 60.25 ± 6.5 94.7 ± 1.3 93.6 ± 2.4 
95% CL (52.6-
68.0) 
95% CL (56.4-
64.2) 
95% CL (93.6-
95.8) 
95% CL (92.2-
95.1) 
Plateau PIPR 
78 ± 12.0 79.1 ± 10.1 94.8 ± 3.6 95.7 ± 2.2 
95% CL (68.0-
88.0) 
95% CL (73.3-
85.0) 
95% CL (91.8-
97.8) 
95% CL (94.3-
97.0) 
Peak PLR 46.1 ± 4.4 43.9 ± 6.1 56.9 ± 7.1 55.1 ± 5.7 
 95% CL (42.5-
49.8) 
95% CL (40.2-
47.6) 
95% CL (51.0-
62.8) 
95% CL (51.7 -
58.6) 
Transient PLR 23 ± 5.5 22 ± 5.2 22.4 ± 8.2 21.4 ± 5.6 
 95% CL (18.3-
27.5) 
95% CL (19-
25.2) 
95% CL (15.5-
29.3) 
95% CL (18-
24.7) 
Time to peak PLR 2.8 ± 0.8 2.5 ± 5.2 1.4 ± 0.2 1.5 ± 0.1 
 95% CL (2.2-
3.5) 
95% CL (2.2-
2.8) 
95% CL (1.3-
1.6) 
95% CL (1.4-
1.5) 
CL, confidence limit; PIPR, post-illumination pupil response; PLR, pupillary light response 
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Figure 15: The 6 s and the plateau PIPR to short and long wavelength light stimuli in 
patients with depression (n = 8) and control participants (n = 13).  
The box and the whisker plots show the median, inter-quartile range and range of the 6 s 
PIPR (left panel) and the plateau PIPR (right panel) in response to red and blue light stimuli. 
There is no significant difference in the 6 s and plateau PIPR in response to short wavelength 
(panel A) test stimuli or long wavelength control (panel B) stimuli between patients with 
depression (open circles) and control participants (filled circles). Amplitudes are expressed as 
percentage baseline pupil diameter.  
4. 3 THE PUPIL LIGHT RESPONSE (PLR) 
The peak pupil constriction amplitudes (peak PLR) and the transient PLR in response to 
1 s short wavelength (blue) and long wavelength (red) light stimuli in patients with 
depression and control participants are shown in Figure 16. There was no significant 
difference between the groups for short wavelength (blue) (p > 0.05, independent t-test) or 
long wavelength (red) stimuli (p > 0.05, independent t-test). The time to peak constriction 
amplitude (Figure 17) in response to short and long wavelength light stimuli were not 
significantly different between the groups (p > 0.05, independent t-test). Since there is an 
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indication that pupil constriction amplitude can be affected by SNRIs (Bitsios et al., 1999; 
Phillips et al., 2000; Siepmann et al., 2007), an additional analysis was done in two patients 
with depression compared to the control participants to examine whether SNRI’s had an 
effect on the pupil constriction. There was no significant effect of SNRIs on the peak PLR in 
response to red (p > 0.05, Mann-Whitney test) and blue (p > 0.05, Mann-Whitney test) 
stimuli in the patients with depression compared to the healthy control group.   
2 0
3 0
4 0
5 0
6 0
7 0
8 0
 P
e
a
k
 P
L
R
 (
%
 b
a
s
e
li
n
e
) A
B lue R ed
0
1 0
2 0
3 0
4 0
5 0
6 0
T
ra
n
s
ie
n
t 
P
L
R
 (
%
b
a
s
e
li
n
e
)
C o n tro l D e p re s s io n
B
C o n tro l D e p re s s io n
 
Figure 16: The peak pupil constriction (peak PLR) and the transient PLR amplitudes to 
short and long wavelength light stimuli in patients with depression (n = 8) and control 
participants (n = 13).  
The box and the whisker plots show the median, inter-quartile range and range of the peak 
PLR (A) and the transient PLR (B) in response to short wavelength blue (left panel) and long 
wavelength red (right panel) stimuli in patients with depression and healthy controls 
measured during 1 s light stimuli. Amplitudes plotted as percentage baseline pupil diameter 
for the patients with depression (open circles) and control participants (filled circles) show no 
significant differences between the groups. 
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Figure 17: The time to peak pupil constriction amplitude (time to peak PLR) to short 
and long wavelength light stimuli in patients with depression (n = 8) and control 
participants (n = 13). 
The box and the whisker plots showing the median, inter -quartile range and range of the time 
to peak PLR amplitude in response to 1 s short wavelength blue (A) and long wavelength red 
(B) stimuli in patients with depression and healthy controls indicates no significant difference 
between the groups. 
4. 4 CONTRAST SENSITIVITY (CS) 
The photopic log contrast sensitivity scores are shown in Figure 18. The log CS were 
not different between the groups (depression, 1.83 ± 0.1, control, 1.76 ± 0.1, p > 0.05, 
independent t-test). The linear regression line of BDI-II scores in the patients with depression 
as a function of log CS was not significantly different from zero (R2 = 0.16; F1, 6 = 01.22; p = 
0.31) indicating that depression severity is not associated with contrast sensitivity in this 
sample of participants. 
 
66 
 
C o ntro l D e p re s s io n
1 .6
1 .7
1 .8
1 .9
2 .0
L
o
g
 C
S
 
Figure 18: Contrast sensitivity in patients with depression and control participants.  
Photopic log contrast sensitivity (CS) measured with the Pelli-Robson chart in patients with 
depression (open circles) and control participants (filled circles) showing no significant 
difference in log contrast sensitivity between the groups. The box and the whisker plots 
indicate median, inter-quartile range and range. 
 4. 5 LIGHT EXPOSURE 
Daily average daylight exposure, nightlight exposure and sleep parameters (sleep 
length, sleep efficiency and sleep onset latency) in patients with depression and control group 
are shown in Table 7. The patients with depression and control participants went to bed at 
similar clock times (~ 23:00 hrs) with the mean time to bed in the patients with depression 
and control participants being 22:59 hrs and 23:16 hrs, respectively. Similarly, the patients 
with depression did not have different times to wake than the control participants with mean 
wake up times in the patients with depression and control participants being 7:36 hrs and 7:37 
hrs, respectively. Hence, their sleep lengths (p > 0.05, Mann-Whitney test) and mid-sleep 
times (p > 0.5, independent t-test) were not significantly different. The sleep efficiency was 
not significantly different between the groups (p > 0.05, Mann-Whitney test). The sleep onset 
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latency was, however, significantly longer for the patients with depression than the control 
participants (p < 0.05, independent t-test). There was no significant correlation between the 
PIPR amplitude and the sleep length (Spearman r = -0.3, p = 0.42), sleep efficiency 
(Spearman r = 0.26, p = 0.53) and sleep onset latency (Spearman r = -0.21, p = 0.61) among 
the patients with depression. 
Table 7: The light exposure and sleep profile compared between the patients with depression 
and healthy control participants. 
 Depression (n = 8) Control (n = 14) P value 
Mean (SD) daylight (lux) 831 (391) 
95% CI (666-1229) 
947 (488) 
95% CI (504-1158) 
0.57 
Median nightlight (lux) 24.5 15 0.76 
Median sleep length (hrs) 8.6 8.1 0.65 
Median sleep efficiency (%) 61 65 0.33 
Mean (SD) sleep onset latency (mins) 20.8 (19.7) 9.1 (3.5) 0.03* 
*p < 0.05; SD, standard deviation; CI, confidence interval 
There was no significant effect of the season and time of the day in light exposure 
levels between the groups (p = 0.95, factorial univariate ANOVA). The combined mean daily 
light exposure levels among the patients with depression and healthy control participants 
were not significantly different between the winter (806 ± 508 lux) and summer (973 ± 410 
lux) (p > 0.1, independent t-test) months. There was no significant correlation between the 
GSE and the mean daylight exposure experienced by the patients with depression (Pearson r 
= 0.40, p = 0.32) and the control participants (Pearson r = 0.27, p = 0.36).  
Daily clock hours light exposure starting and ending at 0:00 hrs and the circadian hours 
light exposure starting with the wake time in patients with depression and healthy control 
participants are shown in Figures 19 (A) and 19 (B) respectively. The Figures show the group 
data (depression; n = 8 and control; n = 14) on a logarithmic lux scale and the symbols show 
the mean and standard deviation.  
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Figure 19: Daily mean (±SD) clock hours (A) and circadian hours (B) light exposure 
presented in logarithmic lux scales in patients with depression and healthy participants.  
Light blue circles (mean ± SD) show the light exposure in the control participants. Dark blue 
squares (mean ± SD) show the light exposure in patients with depression. The illuminance 
(lux) data are expressed on a logarithmic lux scale (log10). Duration of daylight and sleep in 
patients with depression and control participants are shown in the upper panel (A). Actual 
clock hours and sleep duration in patients with depression and control participants are shown 
in the lower panel (B). Scales on the right (A and B) show the typical conditions at which 
specific light exposure levels are experienced. Individuals in both groups experience similar 
light levels most of the time during the day.   
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The mean daylight exposure in the patients with depression was not significantly 
different from that of the control participants (p > 0.05, independent t-test) (Table 7). The 
control participants and the patients with depression experienced similar light exposure of ~ 
2.9 log lux immediately after waking up. After an hour and a half of wake time (9:00 hrs), the 
control participants experienced a peak light exposure of  3.1 log lux which then plateaued 
at ~ 3 log lux for the next 3 hours (10:00 hrs – 13:00 Hrs). Light exposure in the patients with 
depression showed a gradual increase to a peak level of ~ 3 log lux after 6 hours of wake time 
(15:00 hrs). The light exposure levels at clock hours when light levels peaked for both groups 
(9:00 hrs for control participants and 15:00 hrs for patients with depression) did not differ 
significantly (p > 0.05, factorial univariate ANOVA). During the day, both groups were 
exposed to the photopic illumination equivalent to that on an overcast day for at least 8 hours 
after wake time (8:00 to 16:00 clock hours). Both groups experienced light levels equivalent 
to an office light exposure (photopic) between 16:00 to 18:00 clock hours.  During the night 
hours, both groups were exposed to scotopic and mesopic ranges and the median nightlight 
exposure between the groups was not significantly different (p > 0.05, Mann-Whitney test) 
(Table 7). Despite different daylight trends between the groups, the light levels as a function 
of clock hours were not significantly different between the groups (p = 0.90, factorial 
univariate ANOVA).  
The daily mean number of minutes of light exposure experienced by both groups to 
three common illuminance ranges (≥ 10,000 lux, ≥ 5000 lux and ≥ 2500 lux) recommended 
for light therapy in depression is shown in Figure 20. The patients with depression were 
exposed to a light level ≥ 10,000 lux for a mean duration of 21 ± 9 (95% CL: 14-29) min 
daily which was not significantly different (p = 0.6, independent t-test) than the mean 
minutes exposed to ≥ 10,000 lux by the control group (24.6 ± 15 min; 95% CL: 16-33.4). The 
mean duration of daily light exposure in the patients with depression was 36 ± 25.5 (CL: 15-
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57.5) min and 47 ± 37.4 (95% CL: 16-78.5) min daily to exposure levels of ≥ 5000 lux and ≥ 
2500 lux, respectively. Control participants were exposed daily to the light exposure levels ≥ 
5000 lux and ≥ 2500 lux for 40 ± 29 (95% CL: 23-56.5) min and 57.7 ± 44 (95% CL: 32.3-
83) min respectively. The exposure duration between the groups was not significantly 
different for light levels ≥ 5000 lux (p = 0.76, independent t-test) and ≥ 2500 lux (p = 0.58, 
independent t-test). The median group light exposure duration (min) was less than the 
recommended duration (Even et al., 2008; Gallin et al., 1995; Glickman et al., 2006; 
Haffmans et al., 2008; Kräuchi et al., 1990; Meesters et al., 2011; Naus et al., 2013; Szabó et 
al., 2004; Winkler et al., 2005; Wirz-Justice et al., 1999) at ≥ 10,000 lux (30 min), ≥ 5000 lux 
(60 min) or ≥ 2500 lux (120 min).  
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Figure 20: Daily duration of exposure to the illuminance levels ≥ 10000 lux, ≥ 5000 lux 
and ≥ 2500 lux in patients with depression and control participants.  
The box and the whisker plots show the median, inter-quartile range and range of the duration 
(min) spent to light levels ≥ 10,000 lux, ≥ 5000 lux and ≥ 2500 lux by patients with 
depression and control participants. The filled circles and open circles represent cumulative 
minutes to light exposure levels shown under x-axis spent by the control participants and 
patients with depression respectively. The blue horizontal lines represent the recommended 
treatment duration with specific light levels showing none of the groups on average spent 
recommended time daily. 
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CHAPTER 5:  DISCUSSION, CONCLUSIONS AND FUTURE 
DIRECTIONS 
This study examined the role of ipRGCs, the primary cells in the visual system to 
encode ambient environmental light and the relationship of ipRGC function to daily light 
exposure in patients with non-seasonal depressive disorder. There were no differences in the 
ipRGC mediated post-illumination pupil response (PIPR) amplitude measured with a 
Maxwellian view open-loop pupillometer under a high melanopsin excitation condition 
among people with non-seasonal depression and healthy controls (Figure 15). This study did 
not observe any difference in daily ambient light exposure between the patients with non-
seasonal depression and healthy individuals (Figure 19). Moreover, the PIPR amplitude was 
not related to the seasonal change in light exposure levels. The peak PLR, the transient PLR 
and the time to peak PLR amplitudes in response to the short duration, high intensity, short 
and long wavelength light stimuli (Figure 16 and 17) and photopic contrast sensitivity (Figure 
18) were not significantly different between the groups. Taken together, in this participant 
sample, there is no relationship between ambient light exposure and inner retinal (ipRGC) or 
outer retinal (rod and cone) functions in patients with non-seasonal depression. 
While the hypothesis of a reduced PIPR in patients with non-seasonal depression could 
not be confirmed, the findings of a normal PIPR, transient PLR and peak pupil constriction 
amplitudes are supported by a recent study in MDD that included patients with non-seasonal 
depression (n = 12) and SAD (n = 7)  using a Newtonian view pupillometer (Laurenzo et al., 
2016) and stimulus conditions that were optimised to the maximum melanopsin excitation (1 
s stimulus, irradiance ~ 14.8 log quanta.cm-2.s-1) (Adhikari et al., 2015b). A previous study in 
patients with SAD, however, detected a significant reduction in the melanopsin-mediated 
PIPR amplitude (Roecklein et al., 2013) despite using 30 s stimuli with lower retinal 
irradiance (12.3 log quanta.cm-2.s-1) and under closed-loop conditions. While an open-loop 
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pupillometer under high melanopsin excitation conditions as used in the present study may 
have further increased the PIPR amplitude difference (Adhikari et al., 2015b) in the SAD 
study (Roecklein et al., 2013), the current study’s finding also supports different underlying 
pathomechanisms between the patients with non-seasonal depression and SAD.   
Treatment with short wavelength (blue) light is an established therapy in MDD 
(Glickman et al., 2006; Lieverse et al., 2011; Meesters et al., 2011; Royer et al., 2012), yet 
the mechanism of action is poorly understood.  It was hypothesised in the current study that 
the hourly ambient light exposure and the duration spent under light exposure levels 
recommended for depression treatment would be lower and shorter, respectively in the 
patients with non-seasonal depression compared to the healthy control participants reflecting 
the basis of the positive effect of light therapy. This study is the first indicating that the daily 
hourly light exposure levels and the duration spent in bright illumination commonly 
recommended for depression light therapy do not differ between the two groups. None of the 
groups spent the recommended treatment duration of 30 min, 60 min and 120 min under light 
exposure of ≥ 10,000, ≥ 5000 and ≥ 2500 lux, respectively. This is supported by previous 
studies in SAD that also demonstrate similar light exposure levels (Graw et al., 1999; Oren et 
al., 1994) and the duration spent under bright light (> 1000 lux) (Guillemette et al., 1998) 
between patients with SAD and healthy individuals.  Laurenzo et al. (2016) evaluated the 
light exposure levels within the MDD patients only and did not compare them with a control 
group, but showed a significant positive relationship of light exposure levels with the PIPR 
and the transient PLR in response to a high-intensity blue light stimulus. These findings, 
however, need to be confirmed by including a control group. The current study did not show 
a relationship between light exposure and PIPR in both MDD and control groups, possibly 
due to the different geographical locations of light exposure measurement between the two 
studies. Laurenzo et al’s. (2016) study was done in Iowa City, USA in the northern 
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hemisphere where temperatures range between 32°C to -28°C with participants’ individual 
light exposure levels on average, ranging from 2,255 lux in summer to 207 lux in winter 
(Laurenzo et al., 2016). Since, seasonal changes in light exposure have been shown to affect 
the PIPR in normal individuals (Münch et al., 2016), lower PIPR associated with lower light 
exposure is therefore expected in MDD patients (Laurenzo et al., 2016). The current study 
was conducted in Brisbane, Australia, a city in the southern hemisphere, with a sub-tropical 
climate and the study measured similar light exposure levels in the summer and winter 
months. Although the global solar exposure (GSE) during the summer dominating months 
was significantly higher than that during the winter dominating months, the light exposure 
levels between groups with respect to the seasons and the time of the day were not 
significantly different.  Moreover, the GSE measured over the study city (Brisbane) during 
the study recruitment days were not different between the groups. In addition, the daily 
average light exposure in both groups did not change with the GSE over the recruitment 
period, indicating that the season had no effect in light exposure experienced by the study 
participants, most likely due to the distribution of participants in both groups in the current 
study through all seasons. 
The PIPR amplitude in response to blue light stimuli is consistent with a previous research 
that investigated individuals with healthy eyes without depression (Adhikari et al., 2016b) 
using similar stimulus and pupillometry paradigms. The PIPR in response to blue light shows 
a greater variation than to red light. The variation is consistent with previous studies that used 
similar stimulus paradigms as current study (Adhikari et al., 2016b; Maynard et al., 2015). 
The exact biological mechanism is, however, unknown. The variation may have arisen due to 
difference in the density of  ipRGC among human retinae (Dacey et al., 2005; Jusuf et al., 
2007; Liao et al., 2016). The peak PLR (percentage baseline amplitude) in response to red 
light stimuli, however, was slightly higher (5%) compared to that reported by Adhikari et al. 
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(2016b) and this may have occurred due to inter-observer variability. A higher variability in 
the PLR and PIPR amplitudes in the depression group than the control group was seen in the 
present study consistent with a previous study (Laurenzo et al., 2016). The variation may 
have arisen due to different biological mechanisms involved in different sub-types of non-
seasonal depression and the medications used for the treatment. The small sample size of the 
studies may further have contributed to the variations, although the study populations are 
comparable with the pupil study in SAD (Roecklein et al., 2013). The PIPR amplitude among 
SAD patients did not show a variation compared to the healthy controls (Roecklein et al., 
2013) and may reflect the homogeneity of this group’s condition, hence the same biological 
mechanisms among the patients with SAD.  
The PIPR in response to a short wavelength light stimulus is predominantly controlled 
by the OPN projecting M1 ipRGC sub-type which also projects to the mood centres indirectly 
via the SCN in a mouse model (Baver et al., 2008). Depression caused by aberrant light 
exposure is mediated through ipRGC pathway affecting mood, but not the circadian rhythm 
in mice, suggesting a direct mood pathway independent of the SCN (Legates et al., 2012). 
However, based on the results of this study that does not show a relationship between the 
melanopsin-mediated PIPR and non-seasonal depression, it is likely that diurnal humans have 
a normal ipRGC function in non-seasonal depression compared to the nocturnal mice or 
perhaps that mood regulation in non-seasonal depression is driven via other ipRGC sub-types 
that project directly to the mood centres, but not to the SCN or OPN. While a study in mice 
demonstrated that M1 ipRGCs have a direct projection to the SCN and multiple brain nuclei, 
including the OPN, the ventral medial hypothalamus (VMH), the intergeniculate leaflet 
(IGL), the ventral lateral geniculate nucleus (vLGN), the superior colliculus (SC), and peri-
habenular nucleus (pHb) (Fernandez et al., 2016) that have roles in mood, circadian rhythm, 
sleep functions (Gooley et al., 2003; Harrington, 1997; Hattar et al., 2006; Miller, 
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Obermeyer, Behan, & Benca, 1998) and reward (Matsumoto and Hikosaka, 2007),  human 
studies are yet to confirm similar projections of the M1 subtype to the multiple brain areas. 
The projections of M1 ipRGCs to the SCN in mice are greater than those in other brain areas 
(Fernandez et al., 2016) which indicates that M1 ipRGCs have a more prominent role in the 
circadian photoentrainment than in other behavioural functions such as mood. There is also 
evidence that in mice, Brn3b-positive M1 ipRGCs that project to the OPN to control pupil 
light reflex, do not project to the SCN to drive circadian photoentrainment (Chen et al., 2011) 
suggesting two separate pathways. The differentiation of ipRGC based on Brn3b expression 
has not been shown in humans yet, but SAD is likely to be driven by the same M1 ipRGC 
projecting to the OPN and SCN hence affects both, pupil response and circadian rhythm in 
humans. Indeed, SAD is associated with a short photoperiod and prolonged melatonin 
production in winter (Lewy et al., 1987; Wehr et al., 2001) and depression treatment with 
morning light therapy in SAD is brought about by advancing the circadian phase (Burgess et 
al., 2004).    
Importantly, in this sample, the light exposure levels in both groups were within the 
melanopsin activation range (photopic and high mesopic illumination) (Dacey et al., 2005) 
between the wake and sleep times throughout the day and so there would be a normal 
melanopsin signaling for the photoentrainment. Although the light exposure trends were 
different between the groups, both groups, on average, spent most of the time during a day, 
equivalent to the outdoor light levels an individual would experience during an overcast day. 
The evening light exposure in both groups was within the range of indoor office photopic 
light levels. The light exposure during night hours before sleep was within the photopic and 
mesopic ranges in both groups. The light exposure levels in the study participants were also 
not affected by their photoperiod or sleep lengths. The daily photoperiods and sleep lengths 
between the patients with depression and healthy control participants were not significantly 
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different. Individuals in both groups had similar wake times and received the last light at 
similar times. Hence, the apparent photoperiods (wake time to time of last light) were similar. 
The subjective sleep onset latency was significantly longer in the depression group, which is 
consistent with a previous study (Lovato & Gradisar, 2014). The Actigraphy-derived sleep 
efficiency and sleep lengths were not different between the groups. Depression is, however, 
thought to be accompanied by sleep and circadian rhythm abnormalities (Argyropoulos et al., 
2005; Borbély et al., 1982; Lovato et al., 2014; Wirz-Justice, 2006). Normal sleep efficiency 
and sleep length found in this study could be confounded by the medication used by the 
patients with depression (Appelboom-Fondu, Kerkhofs, & Mendlewicz, 1988; Lemoine, 
Guilleminault, & Alvarez, 2007). The sleep onset latency, however, did not correlate 
significantly with the PIPR amplitude indicating that there was no interaction between the 
melanopsin function and sleep onset latency in non-seasonal depression.     
The visual function measured as log contrast sensitivity (CS) was not different between 
the groups. While a previous study (Wesner et al., 2006) measured the CS to Gabor targets of 
various spatial and temporal frequencies in patients with seasonal and non-seasonal 
depression with normal vision and observed an increased CS, more recent studies with 
different methodologies and larger sample sizes showed a reduced contrast sensitivity in 
patients with non-seasonal depression (Bubl et al., 2009; Fam et al., 2013). Retinal 
dopaminergic dysregulation has been hypothesised to affect the visual contrast sensitivity in 
patients with non-seasonal depression (Bubl et al., 2009; Fam et al., 2013). No study has, 
however, reported a direct measure of retinal dopamine in depression. M1 ipRGCs are 
believed to modulate cone adaptation via their retrograde axonal collaterals to the inner 
plexiform layer (IPL) where they synapse with the dopaminergic amacrine cells (Joo et al., 
2013). Visual functions are partially controlled by retrograde signaling of ipRGCs to the 
outer retinal photoreceptors via the dopaminergic system in the retina (Prigge et al., 2016). 
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This study showing normal ipRGC function and visual contrast sensitivity suggests a normal 
dopaminergic neurotransmission within the retina in non-seasonal depression. This 
assumption needs to be, however, interpreted with caution as common antidepressant 
medications (e.g. SSRIs) may decrease the central dopaminergic activity (Esposito, 2006).  
In summary, this study observed a normal melanopsin function and light exposure in 
non-seasonal depression patients residing in Brisbane, Australia. In non-seasonal depression, 
diurnal humans, possibly have a robust ipRGC function compared to the nocturnal animal 
models that show depressive behaviour in response to aberrant light (Legates et al., 2012) or 
mood disorder in non-seasonal depression in humans is modulated by other sub-types of 
ipRGCs that were not measured in this study. It is, however, well recognised that depression 
is a multifactorial condition (Goldberg, 2006) and it is likely that higher brain centres play a 
role in the pathophysiological processes independently of ipRGC function and ambient light 
exposure and these relationships require further exploration. 
5. 1 LIMITATIONS 
The study suggests similar mean PIPR amplitude between the groups, indicating that 
there is no effect of non-seasonal depression on the melanopsin function. The result of the 
study may have been underpowered due to the small sample size that estimated 45 samples 
per group based on the mean and standard deviation of the samples from the previous SAD 
study (Roecklein et al., 2013). The patient number was limited by the nature of the disease 
and recruitment difficulties.  The sample size of this study is, however, comparable to the two 
other studies that evaluated the melanopsin function in patients with depression (Laurenzo et 
al., 2016; Roecklein et al., 2013); Roecklein et al. (2013) investigated 15 patients with SAD 
and Laurenzo et al. (2016) evaluated 12 patients non-seasonal depression. The sample size of 
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the current study is also comparable to previous studies investigating light exposure in 11 
(Guillemette et al., 1998) and 13 (Oren et al., 1994) patients with SAD.  
Antidepressants (SNRIs and SSRIs) are known to affect the autonomic nervous system 
(Richelson, 1994), hence influence the resting pupil diameter and pupillary responses (Bär, 
Greiner, Jochum, Friedrich, Wagner, & Sauer, 2004; Bitsios et al., 1999; Phillips et al., 
2000). There is evidence that the SNRI class of antidepressants affects the baseline pupil 
diameter, pupil constriction amplitude and pupil recovery time after light offset (Bitsios et al., 
1999; Phillips et al., 2000; Siepmann et al., 2007). The present study had two patients with 
depression taking SNRIs. The pupil responses of those taking and not taking SNRIs were, 
however, not different than that of the healthy controls, indicating no effect of SNRIs on the 
patient’s pupil data. The effect of SSRI on the baseline pupil diameter is described 
inconsistently (Bitsios et al., 1999; Phillips et al., 2000; Schmitt et al., 2002) showing no 
change (Bitsios et al., 1999; Phillips et al., 2000) or an increased pupil diameter (Schmitt et 
al., 2002) in individuals using SSRIs. Seven patients in the depression group were taking 
SSRIs, however, there was no significant difference in baseline pupil diameter in the patients 
taking SSRIs compared to the healthy controls. To account for the baseline pupil differences 
that might have occurred due to the use of the medications, the PLR and PIPR data of the 
participants in both groups were normalized to their individual baselines as percentage 
baseline amplitudes. 
Three participants in this study had recurrent depressive episodes with the maximum 
number of episodes being two and the minimum duration of onset being two years. Although 
these patients scored higher than cutoff on the atypical HDRS-SAD scale, a diagnosis of 
winter SAD could not be made as the peak depressive symptoms during winter with 
remission during the summer was not confirmed. Studies suggest inconsistencies with the 
HDRS scale (Uher, Farmer, Maier, Rietschel, Hauser, Marusic, Mors, Elkin, Williamson, 
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Schmael, Henigsberg, Perez, Mendlewicz, Janzing, Zobel, Skibinska, Kozel, Stamp, Bajs, 
Placentino, Barreto, McGuffin, & Aitchison, 2008) and inter-rater discrepancies with HDRS-
SAD with respect to the atypical SAD mood symptoms like “fatigability” and ‘hypersomnia” 
(Rohan et al., 2016). It is unlikely that SAD participants have been included in this study as 
none of the participants had a self-reported history of SAD with worst mood during winter 
and complete remission during summer.  
Light exposure data should be interpreted with caution as an accurate measurement of 
light exposure by an ambulatory light sensor may be limited by the performance of the device 
(Cao et al., 2015b). While a Daysimeter is a device that has a light sensor at eye level 
(Smolders et al., 2013), the Actiwatch-L (Philips Respironics, Eindhoven, Netherlands) has 
been validated against the Daysimeter (Rensselaer Polytechnic Institute, Troy, NY) in 
patients after cardiac surgery showing that the Actiwatch-L underestimates eye level light 
exposure by < 10 lux at light levels < 5000 lux (Jardim, Pawley, Cheeseman, Guesgen, 
Steele, & Warman, 2011); the difference increases with increase in light exposure at eye 
level. The spectral output from the Actiwatch used under direct exposure to sunlight  also 
underestimate the actual light level (Cao et al., 2015b). Cao et al., 2015 suggests that the red-
green-blue (RGB) spectral Actiwatch underestimates 0.123-0.230 log units for long 
wavelength light (red) and 0.145 log units for short wavelength light (blue) than the actual 
level, whereas the light estimates for medium wavelength (green) are more accurate. The 
light level estimation by the light sensors in an ambulatory device is suggested to also vary 
with the ambient temperature (Cole, Kripke, Wisbey, Mason, Gruen, Hauri, & Juarez, 1995). 
This study was aimed to compare the ambient light exposure levels between two groups, and 
both groups used the same devices. Hence, any differences in the light measurements within 
the groups would not affect the actual difference between the groups. Further, this study did 
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not have control over ambient indoor temperatures, although the outdoor global solar 
exposure (GSE) was not different between the participants.  
Estimation of the nightlight exposure levels during sleep may be affected by sleep 
disturbance among the participants and the light sensors being covered by the clothes. It is, 
however, unlikely that nightlight data were affected by sleep disturbance as sleep efficiency 
between the groups was not significantly different. Nonetheless, the nightlight exposure 
during sleep may be of less relevance to the image and non-image-forming functions as a 
person's eyes are closed during sleep.  
5. 2 CONCLUSION AND FUTURE DIRECTIONS 
This thesis addressed an important question of ambient light exposure and its 
relationship with the non-image forming (ipRGCs) functions in non-seasonal depression.  
 An ambulatory Actigraphy device was used to measure the ambient light exposure 
levels and a custom built Maxwellian view open-loop pupillometer with previously optimised 
stimulus paradigms (Adhikari et al., 2015b) was used to compare the inner retinal ( ipRGC) 
and outer retinal (rod-cone) function by measuring the PIPR and PLR amplitudes  in response 
to red and blue light stimuli in patients with depression and healthy control participants. The 
daily hourly light exposure levels and duration spent to bright illumination daily did not show 
a relationship with non-seasonal depression. No relationship of light exposure to the inner 
retinal melanopsin and outer retinal rod and cone functions in non-seasonal depression was 
shown by the study. This finding expands previous knowledge in depressive disorders.  
Depression is a multi-factorial condition and this study suggests, while M1 ipRGCs that 
project to the OPN and the SCN are dysfunctional in SAD (Roecklein et al., 2013), they are 
not dysfunctional in non-seasonal depression. The lack of a significant correlation between 
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the melanopsin-mediated PIPR and circadian parameters (sleep length, sleep efficiency and 
sleep latency) in the current study provides further evidence to this conclusion. Projections of 
M1 ipRGC to multiple brain targets in animal models have been confirmed (Fernandez et al., 
2016). There is, however, limited knowledge of M1 ipRGC projections to the mood centres 
in humans. Future studies should focus on human research into ipRGC sub-types and their 
projections to the brain nuclei. Studies may be initiated in primates (e.g., macaque) that 
resemble humans in many aspects.  
A normal melanopsin function and light exposure levels in non-seasonal depression 
patients indicate that improvement in depression symptoms with light therapy is independent 
of the ambient light exposure. While there is a relationship between light exposure and 
depression (Ashkenazy-Frolinger et al., 2010; Ashkenazy et al., 2009; Bedrosian et al., 2011; 
Fonken et al., 2009; Fonken et al., 2012; Fujioka et al., 2011; Legates et al., 2012; Workman 
et al., 2011) and an association between ipRGC and non-seasonal depression has been clearly 
established in animal models (Legates et al., 2012), such experiments with controlled light 
exposure have not been conducted in humans for ethical reasons. Future research in humans 
with and without ipRGC dysfunction for instance, due to retinal disease (Adhikari et al., 
2016b; Feigl et al., 2011; Feigl et al., 2014; Kankipati et al., 2011; Kardon, Anderson, 
Damarjian, Grace, Stone, & Kawasaki, 2011; Kelbsch et al., 2016; Markwell et al., 2010; 
Maynard et al., 2015; Obara, Hannibal, Heegaard, & Fahrenkrug, 2016) can be done to 
understand the effect of light on mood and behaviour with respect to the changes in light 
exposure characteristics like wavelength, intensity, duration of light-dark cycle and their 
effects on the melatonin profile.  
Moreover, light exposure is subject to high variation as it is influenced by season, 
geography, the individual’s occupation, indoor artificial lighting and sleep-wake habits (Cole 
et al., 1995; Gou et al., 2015; Savides, Messin, Senger, & Kripke, 1986; Shochat, Martin, 
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Marler, & Ancoli-Israel, 2000; Smolders et al., 2013; Thorne, Jones, Peters, Archer, & Dijk, 
2009). Future research on light exposure with respect to the season, occupation and lifestyle 
in population with depression is required. Daily logs of the type of artificial light and duration 
of the exposure to artificial lights can be incorporated to understand the difference in natural 
and artificial light exposure. Since the light sensors in ambulatory devices may over- or 
under-estimate light (Cao et al., 2015b; Jardim et al., 2011), future studies could use light 
sensors at eye level (Daysimeter) to give a more accurate estimation of daily ocular light 
exposure (Jardim et al., 2011; Smolders et al., 2013).  
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APPENDICES 
This chapter includes the participant’s individual pupil light reflex in response to short 
wavelength (blue) and long wavelength (red) light stimuli and the tools that were used for 
psychological and light exposure assessment.  
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1.0 THE PUPIL LIGHT RESPONSE IN DEPRESSION AND CONTROL 
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Individual pupil light reflex traces in patients with (n = 8). The mean pupil light reflex 
traces in response to 1 s (black rectangle) long wavelength (red) and short wavelength (blue) 
light stimuli in patients with depression. The blue and red lines show the mean of the repeats 
with blue and red light stimuli respectively. The vertical line denotes 6-second PIPR 
amplitude. 
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Individual pupil light reflex traces in control group (n = 13). The mean pupil light reflex 
traces in response to 1 s (black rectangle) long wavelength (red) and short wavelength (blue) 
light stimuli in control group. The blue and red lines show the mean of the repeats with blue 
and red light stimuli respectively. The vertical line denotes 6-second PIPR amplitude. 
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2.0 THE MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW 
(MINI_6) 
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3.0 THE HAMILTON DEPRESSION RATING SCALE -SEASONAL 
AFFECTIVE DISORDER VERSION (HDRS-SAD) 
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7.0 THE SEASONALITY ASSESSMENT FORM (SAF)  
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